homocysteine has been researched along with Coronary Artery Disease in 408 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.25) | 18.7374 |
1990's | 31 (7.60) | 18.2507 |
2000's | 249 (61.03) | 29.6817 |
2010's | 98 (24.02) | 24.3611 |
2020's | 29 (7.11) | 2.80 |
Authors | Studies |
---|---|
Guo, Y; Han, W; Jia, S; Liu, X; Sun, J; Wu, S; Yan, Z; Zhao, Y; Zhou, Y | 1 |
Gui, C; Huang, Q; Jian, W; Ma, X; Mo, C; Xu, Y; Yang, Z; Zheng, W | 1 |
Chen, D; Wang, L; Wu, Y; Xiang, Y; Xie, C; Zhan, Y; Zhang, Z | 2 |
Chang, Y; Dai, W; Liu, Y; Pan, H; Qi, Y; Wang, T; Wang, X; Wang, Z; Zhang, W; Zhao, J | 1 |
Romdoni, R; Sargowo, D; Sugijo, H; Widjajanto, E | 1 |
Araki, M; Chou, S; Das, S; Dijkstra, J; Ishibashi, M; Jang, IK; Kawamoto, H; Kobayashi, K; Kurita, N; Kuter, D; Lee, H; Matsuoka, S; McNulty, I; Mitomo, S; Naganuma, T; Nakajima, A; Nakamura, S; Okutsu, M; Onishi, H; Seegers, LM; Tahara, S; Tanaka, K; Watanabe, Y; Yabushita, H; Yuki, H | 1 |
Alawneh, I; Daraghmeh, M; Jabri, D; Saymeh, A; Yaseen, L | 1 |
Araki, M; Chou, S; Dijkstra, J; Ishibashi, M; Jang, IK; Kawamoto, H; Kobayashi, K; Kurita, N; Kuter, DJ; Lee, H; Libby, P; Matsuoka, S; McNulty, I; Mitomo, S; Naganuma, T; Nakajima, A; Nakamura, S; Okutsu, M; Onishi, H; Ouchi, T; Sato, T; Seegers, LM; Tahara, S; Tanaka, K; Watanabe, Y; Yabushita, H; Yuki, H | 1 |
Jakubowski, H; Perła-Kaján, J; Sikora, M; Skrzydlewski, P | 1 |
Chen, L; Chen, Y; He, Z; Huang, G; Li, J; Peng, L; Sun, H; Wang, J; Xiao, K; Xiao, L; Xv, L; Xv, Y | 1 |
Eun, YM; Kim, HN; Song, SW | 1 |
Shao, Y; Yuan, W; Zhang, B; Zhao, D | 1 |
He, GW; Lun, LM; Tian, QW; Xuan, C; Yue, K; Zhang, SY; Zhang, XC; Zhao, P; Zhu, J | 1 |
Kiouri, E; Kosmas, N; Pavlakis, G; Rallidi, T; Rallidis, LS; Zolindaki, M | 1 |
Rai, PS; Satyamoorthy, K; Sharma, AR; Shashikiran, U; Shetty, R; Uk, AR | 1 |
Cui, Z; Jia, Y; Li, F; Li, S; Qi, L; Sun, L; Wang, Z; Zhao, X | 1 |
Baptista, J; Ferin, R; Fontes, A; Lima, A; Martins, D; Pavão, ML; Santos, E | 1 |
Ben Messaoud, M; Bouzidi, N; Ferchichi, S; Fodha, H; Gamra, H; Hassine, M; Maatouk, F | 1 |
Bosevski, M; Gjorgievski, A; Lazarova, E; Petkoska, D; Stojanovska, L; Zlatanovikj, N | 1 |
Bruzzese, L; Chefrour, M; Criado, C; Cuisset, T; Deharo, P; Fenouillet, E; Fromonot, J; Gastaldi, M; Gaubert, M; Gaudry, M; Guieu, R; Guiol, C; Kipson, N; Mace, P; Marlinge, M; Mottola, G; Paganelli, F; Ruf, J; Vairo, D | 1 |
Gu, J; Li, D; Tong, W; Tsheko, T; Zhou, R | 1 |
Chen, S; Fu, G; Wang, Y; Xu, T; Yang, F; Zhang, K; Zhang, W | 1 |
Choi, BH; Joo, NS; Jung, S; Kim, YN | 1 |
Chen, Z; Feng, J; Jin, X; Pan, J; Zhang, J; Zhou, G | 1 |
De Luca, G; Gioscia, R; Marcolongo, M; Nardin, M; Negro, F; Saghir Afifeh, AM; Verdoia, M; Viglione, F | 1 |
De Luca, G; Gioscia, R; Nardin, M; Negro, F; Verdoia, M | 1 |
Deng, GX; Li, H; Miao, L; Nie, RJ; Wang, Y; Yang, S; Yin, RX | 1 |
Cao, YW; Diao, JY; Gao, TJ; Wu, HY; Yao, XW; You, PH | 1 |
DiNicolantonio, JJ; McCarty, MF; O'Keefe, JH | 1 |
Duan, L; Hu, J; Liu, Y; Wang, J; Xiong, X | 1 |
Glowacki, R; Karolczak, K; Kubalczyk, P; Pietruszynski, R; Watala, C | 1 |
Cushman, M; Duan, Q; Durda, P; Ellis, J; Gross, MD; Keating, BJ; Lange, EM; Lange, LA; Li, J; Li, Y; Olson, NC; Pankratz, N; Raffield, LM; Reiner, AP; Rich, SS; Tracy, RP; Wassel, CL; Willis, MS; Wilson, JG | 1 |
Lian, Z; Lv, FF; Wang, JW; Yu, J | 1 |
Cohen, E; Goldberg, E; Krause, I; Margalit, I; Shochat, T | 1 |
Okabe, F; Otsuka, K; Shimizu, K; Shimose, T; Shirai, K; Suzuki, K; Takahashi, K; Takata, M; Tsuda, S; Tsuji, Y; Uchino, J; Yamamoto, T | 1 |
Chang, FJ; Chen, HC; Cheng, G; Han, WQ; Min, ZQ; Wang, JW; Wang, Y; You, PH; Zhong, NE | 1 |
Chen, H; Li, S; Niu, X; Pan, G | 1 |
He, Z; Hu, Y; Huang, Y; Li, W; Wu, S; Wu, Y; Xu, D; Yang, Y; Zhong, J | 1 |
Ahmadi, N; Budoff, M; Ebrahimi, R; Flores, F; Hajsadeghi, F; Nabavi, V; Zeb, I | 1 |
Garg, MK; Kulkarni, MV; Mahalle, N; Naik, SS | 1 |
Chen, Y; Li, W; Wu, S; Wu, Y; Zhong, J | 1 |
Drzewoski, J; Kamysz, W; Karafova, A; Karolczak, K; Watala, C | 1 |
Ahmadi, KR; Bandinelli, S; Bis, JC; Blom, H; Brown, MJ; Chambers, JC; Chasman, DI; Chen, C; Chen, YD; Clarke, RJ; Cotlarciuc, I; Dehghan, A; den Heijer, M; Erdmann, J; Ferrucci, L; Goel, A; Hamsten, A; Hazra, A; Hofman, A; Hunter, DJ; Jacques, P; Johnson, AD; Kampman, E; Kathiresan, S; Kiel, DP; Kiemeney, LA; Kooner, JS; Kraft, P; Lindemans, J; Mälarstig, A; McKnight, B; Mooser, V; Nelson, CP; O'Donnell, CJ; Pare, G; Psaty, BM; Rader, DJ; Reilly, MP; Ridker, PM; Rivadeneira, F; Rose, LM; Samani, NJ; Schunkert, H; Schwartz, SM; Seedorf, U; Selhub, J; Siscovick, DS; Tanaka, T; Ueland, PM; Uitterlinden, AG; van Meurs, JB; Vermeulen, SH; Vollenweider, P; Waeber, G; Waterworth, DM; Watkins, H; Witteman, JC; Yuan, X | 1 |
George, R; Gopu, CL; Hari, PR; Harikrishnan, S; Sreenivasan, K | 1 |
Başaran, Y; Geçmen, Ç; Gürel, E; Karaahmet, T; Mutlu, B; Tigen, K | 1 |
Cosar, A; Gultepe, M; Muftuoglu, T; Ozcan, O | 1 |
Kang, JH; Kim, BJ; Kim, BS | 1 |
Bahari, M; Jooyan, N; Karimi, M; Saffari, B; Senemar, S; Yavarian, M | 1 |
Dhall, A; Garg, S; Gupta, SK; Kotwal, A; Kotwal, J | 2 |
Abdi, S; Basati, G; Razavi, AE; Sarrafzedegan, N | 1 |
Gao, L; Liu, Y; Tian, T; Zhang, H; Zhou, X | 1 |
Barbieri, L; Bellomo, G; Luca, GD; Marino, P; Niccoli, G; Perrone-Filardi, P; Schaffer, A; Suryapranata, H; Verdoia, M | 1 |
Cassetti, E; De Luca, G; Marino, P; Schaffer, A; Suryapranata, H; Verdoia, M | 1 |
Balli, M; Batyraliev, T; Cagliyan, CE; Ipek, E; Sercelik, A; Tekin, K; Turkmen, S; Yolcu, M | 1 |
Ahmed, M; Errett, L; Jenkins, DJ; Keith, M; Kuliszewski, MA; Leong-Poi, H; Liao, C; Peeva, V; Sorokin, K; Tran, S | 1 |
Gao, J; Jia, X; Mou, W; Sun, Q; Tian, Y; Tong, H; Wen, X | 1 |
Fu, C; Nie, S; Sun, K; You, Y | 1 |
Araki, Y; Fujita, K; Hojo, Y; Ichikawa, S; Iwasaki, T; Kanai, H; Kasama, S; Kumakura, H; Minami, K; Nakashima, K | 1 |
Chasman, DI; Cornelis, MC; Fornage, M; Foy, M; Gladyshev, VN; He, K; Hu, FB; Jordan, JM; Kraft, P; Morris, S; Mozaffarian, D; Rimm, EB; Xun, P | 1 |
Akaydın, S; Ardıç, S; Darılmaz Yüce, G; Durusu, M; Ergün, R; Fırat, H; Ortaç Ersoy, E; Özkan, Y; Topeli, A | 1 |
Frölich, JC; Hahn, A; Kayacelebi, AA; Pham, VV; Rothmann, S; Schneider, JY; Tsikas, D; Willers, J | 1 |
Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Pergolini, P; Rolla, R; Schaffer, A; Sinigaglia, F; Suryapranata, H; Verdoia, M | 1 |
Chen, X; Hou, X; Shi, J | 1 |
Alama, MN; Almehdar, HA; Alzahrani, AS; Damanhouri, GA; Firoz, CK; Jabir, NR; Kamal, MA; Khan, W; Tabrez, S | 1 |
Chen, S; Chen, Z; Han, L; Liu, S; Ma, J; Peng, X; Wang, C; Zhao, D | 1 |
Balsat, M; Bert, A; Blond, E; Drai, J; Escoffre-Barbe, M; Etienne, G; Etienne, M; Fossard, G; Giraudier, S; Heiblig, M; Labussière-Wallet, H; Lega, JC; Mahon, FX; Morisset, S; Nicolini, FE; Redonnet-Vernhet, I; Sobh, M | 1 |
Cha, DH; Jeon, YJ; Kim, IJ; Kim, JO; Kim, NK; Kim, OJ; Kim, SH; Lee, BE; Lim, SW; Moon, JY; Sung, JH | 1 |
Bonatti, S; Bruzzese, L; Cuisset, T; Deharo, P; Fenouillet, E; Fromonot, J; Guieu, R; Mottola, G; Quilici, J; Ruf, J | 1 |
Cheng, T; Hou, J; Kong, W; Ma, G; Qiao, Y; Sha, X; Tang, C; Wang, D; Yan, G; Zhang, H | 1 |
Broncel, M; Chwatko, G; Jackowska, P; Koter-Michalak, M; Kubalczyk, P; Olszewska-Banaszczyk, M; Pytel, E | 1 |
Barbieri, L; Cassetti, E; De Luca, G; Schaffer, A; Suryapranata, H; Verdoia, M | 1 |
Chen, YY; Wang, BN; Yu, XP | 1 |
Abbate, R; Boddi, M; Cioni, G; Gensini, GF; Giglioli, C; Gori, AM; Marcucci, R; Valente, S | 1 |
Dolgoshey, TS; Doroshenko, EM; Rubinsky, AY; Smirnov, VY; Snezhitsky, VA; Yatskevich, ES | 1 |
Athyros, VG; Katsiki, N; Mikhailidis, DP | 1 |
Daida, H; Dohi, T; Hassan, A; Isoda, K; Kurano, M; Miyauchi, K; Nakamura, K; Ogita, M; Ohkawa, R; Okazaki, S; Tamura, H; Yatomi, Y | 1 |
Bickel, C; Blankenberg, S; Lackner, K; Lubos, E; Proust, C; Rupprecht, H; Schnabel, RB; Sinning, C; Tregouet, D; Westermann, D; Zengin, E | 1 |
Hu, GX; Li, YH; Mou, L; Qiao, LJ; Tian, YG; Zhang, J | 1 |
Chang, SH; Chen, CC; Chen, DY; Hsieh, IC; Hsieh, MJ; Lee, CH; Tsai, ML; Wang, CY; Yang, CH; Yeh, JK | 1 |
Chen, D; Fang, K; Gao, P; Hu, Y; Li, J; Liu, K; Qin, X; Song, J; Sun, K; Tang, X; Wang, L; Wang, X; Wu, T; Wu, Y | 1 |
Schooling, CM; Zhao, JV | 1 |
Almeida, BR; Brito, CJ; Córdova, C; Daros, AC; Ferreira, AP; Gomes, L; Machado-Silva, W; Moraes, CF; Nóbrega, OT; Paula, RS; Souza, VC | 1 |
Huang, C; Liu, C; Luo, J; Ma, Y; Peng, D | 1 |
Furusyo, N; Hayashi, J; Maeda, S; Ohnishi, H; Sawayama, Y; Tatsukawa, M | 1 |
Cheng, CH; Huang, MC; Huang, YC; Lee, BJ; Lin, PT; Tsai, TP | 1 |
Van Wagoner, DR | 1 |
Brahmachari, V; Garg, G; Karthikeyan, G; Kumar, A; Kumar, J; Patowary, A; Ramakrishnan, L; Sengupta, S; Sharma, P | 1 |
Bleie, Ø; Ebbing, M; Nilsen, DW; Nordrehaug, JE; Nygård, O; Pedersen, EK; Refsum, H; Ueland, PM; Vollset, SE | 1 |
Armstrong, DJ; Kumar, N | 1 |
Cucchiara, AJ; Hammons, AL; Mohr, E; Nackos, E; Summers, CM; Von Feldt, JM; Whitehead, AS | 1 |
Kristofova, B; Valocik, G; Valocikova, I | 1 |
Jarosz, A; Nowicka, G | 1 |
Antoniades, C; Antonopoulos, AS; Marinou, K; Stefanadis, C; Tousoulis, D | 1 |
Hatzitolios, A; Ntaios, G; Savopoulos, C | 1 |
Pessina, AC; Rossi, GP; Seccia, TM | 2 |
Scholl, J | 1 |
Chen, Z; Li, CS; Liu, MB; Wang, JJ | 1 |
Abbasaliyev, A; Alioglu, E; Cam, S; Ercan, E; Tengiz, I; Turk, U | 1 |
Altinbaş, A; Demir, M; Doğan, A; Ozaydin, M; Varol, E | 1 |
Aydin, M; Gokkusu, C; Ozbek, Z; Ozkok, E; Pamukcu, B; Tulubas, F; Umman, B; Unlucerci, Y | 1 |
Lundberg, GD | 1 |
Attia, N; Ben Farhat, M; Ben Hamda, K; Hammami, M; Hammami, S; Koubaa, N; Mehri, S; Miled, A; Nakbi, A | 1 |
Biselli, PM; Carvalho, VM; de Godoy, MF; Eberlin, MN; Goloni-Bertollo, EM; Guerzoni, AR; Haddad, R; Pavarino-Bertelli, EC; Vannucchi, H | 1 |
Geng, HL; Liang, Y; Rong, GH; Wu, WL; Xiong, YS; Yang, ZX; Zhong, RQ; Zhou, YH | 1 |
Carru, C; Hare, DL; Jin, X; Lau, E; Learmont, J; Schwartz, GD; Sutarga, K; Wijaya, BP; Wookey, PJ; Zinellu, A; Zulli, A | 1 |
Antoniades, C; Baarholm, OA; Channon, KM; Cunnington, C; Leeson, P; Pillai, R; Ratnatunga, C; Refsum, H; Shirodaria, C; Stefanadis, C; Tousoulis, D; Van-Assche, T | 1 |
Karatela, RA; Sainani, GS | 1 |
Böhm, BO; Fuchs, D; Grammer, T; März, W; Meinitzer, A; Murr, C; Schroecksnadel, K | 1 |
Biselli, PM; Eberlin, MN; Godoy, MF; Goloni-Bertollo, EM; Guerzoni, AR; Haddad, R; Pavarino-Bertelli, EC; Souza, DR | 1 |
Beal, R; Eberhardt, RT; Handy, D; Holbrook, M; Jahangir, E; Loscalzo, J; Palmisano, J; Vita, JA | 1 |
Chan, EC; Chen, YC; Cheng, ML; Chiu, DT; Ho, HY; Lin, JF | 1 |
Averna, MR; Bivona, G; Cefalù, AB; Chiarello, G; Ciaccio, M; Falletta, A; Noto, D; Sasso, BL; Vivona, N | 1 |
Assali, A; Battler, A; Hasdai, D; Koren-Morag, N; Kornowski, R; Lev, IE; Mager, A; Orvin, K; Shohat, M | 1 |
Abedi, SA; Bohlooli, A; Nakhjavani, MR; Tarzamni, MK | 1 |
Kapelak, B; Plicner, D; Sadowski, J; Stepień, E; Undas, A; Wypasek, E | 1 |
Chen, CC; Hsieh, IC; Hsieh, MJ; Lee, CH; Lee, TH; Lin, FC; Wen, MS; Wu, D | 1 |
Lennie, TA; Son, YJ; Song, EK | 1 |
Thiengburanatham, S | 1 |
Boehm, BO; Fuchs, D; Grammer, TB; März, W; Schroecksnadel, K | 1 |
Besanger, A; Biffi, A; Butler, C; Chang, Y; Cloonan, L; Delgado, P; Furie, KL; Gilson, A; Jimenez-Conde, J; Kanakis, A; Massasa, E; Rahman, R; Rosand, J; Rost, NS; Silva, G; Smith, EE; Sonni, S | 1 |
Bleie, O; Blix, AJ; Ebbing, M; Løland, KH; Nordrehaug, JE; Nygård, O; Refsum, H; Strand, E; Ueland, PM | 1 |
Chudek, J; Demkow, M; Dzielinska, Z; Januszewicz, A; Januszewicz, M; Makowiecka-Ciesla, M; Naruszewicz, M; Prejbisz, A; Ruzyllo, W; Tyczynski, P; Wiecek, A; Zielinski, T | 1 |
Attia, N; Ben Farhat, M; Hammami, M; Hammami, S; Koubaa, N; Mehri, S; Nakbi, A | 1 |
Wu, Y; Yang, L; Zhong, L | 1 |
Chang, LY; Lin, T; Liu, JC; Shen, CW | 1 |
Ardic, I; Celik, A; Ceyhan, K; Erdem, S; Kadi, H; Kalay, N; Kaya, MG; Koc, F; Onalan, O; Ozbek, K; Sahin, S; Taner, A; Yarlioglues, M | 1 |
Agoşton-Coldea, L; Gatfossé, M; Mocan, T; Rosenstingl, S; Seicean, A | 1 |
Chopra, V; Eagle, KA | 1 |
Głuszek, J; Pawlak, A; Radziemski, A; Strauss, E | 1 |
Khalil, A; Khalil, S; Mallika, V; Mandal, K | 1 |
Bleie, Ø; Igland, J; Nordrehaug, JE; Nygård, OK; Refsum, H; Strand, E; Ueland, PM; Vollset, SE | 1 |
Bang, OY; Choe, YH; Kim, SJ | 1 |
Khaghani, S; Pasalar, P; Pourmotabbed, T; Rahimi, Z; Rezaie, M; Saedi, M; Shariftabrizi, A; Vaisi-Raygani, A | 1 |
Masud, R; Qureshi, IZ | 1 |
Huque, MM; M Giasuddin, AS; Mujibul Haq, AM | 1 |
Balogh, E; Bereczky, Z; Czuriga, I; Edes, I; Katona, E; Koszegi, Z; Muszbek, L | 1 |
Li, D; Ling, W; Lv, X; Ma, J; Qiu, J; Su, D; Xia, M; Xiao, Y; Zhang, Y | 1 |
Baker, JF; Cucchiara, A; Lazar, MA; Morales, M; Nackos, E; Qatanani, M; Teff, K; von Feldt, JM | 1 |
Hoffman, TA; Irani, K; Jeon, BH; Jung, SB; Kim, CS; Kim, YR; Kumar, A; Kumar, S; McNamara, DM; Naqvi, A | 1 |
Karska-Basta, I; Kubicka-Trząska, A; Romanowska-Dixon, B; Undas, A | 1 |
Afonso, L; Niraj, A; Panaich, S; Ramesh, K; Veeranna, V; Zalawadiya, S | 1 |
Chai, HT; Chang, LT; Chen, HC; Chen, YL; Chung, SY; Fan, CQ; Sun, CK; Sung, PH; Tsai, TH; Yang, CH; Yip, HK | 1 |
Majumder, PP; Mallik, S | 1 |
Fallah, S; Korani, M; Norouzi, V; Samadikuchaksaraei, A; Seifi, M | 1 |
Baños-González, MA; Barragán-García, R; Cardoso-Saldaña, G; de la Peña-Díaz, A; Delgado-Granados, H; Herrera-Alarcón, V; Linares-López, C; Martínez-Ríos, MA; Peña-Duque, MA; Rodríguez-Lobato, LG; Valente-Acosta, B | 1 |
Huang, C; Pan, H; Wang, Z; Zhang, L; Zhu, J | 1 |
Choo, SC; Khor, GL; Loh, SP; Rozita, R; Sabariah, MN | 1 |
Cui, H; Fan, L; Hong, CM; Hu, GL; Hu, YX; Liu, L; Wang, F | 1 |
Chen, SJ; Huang, YC; Lee, BJ; Lin, PT | 1 |
Abchee, AB; Badro, DA; Cazier, JB; Chammas, E; Douaihy, B; el Bayeh, H; Gauguier, D; Ghassibe-Sabbagh, M; Haber, M; Hager, J; Kamatani, Y; Kibbani, S; Milane, A; Nemr, R; Othman, R; Platt, DE; Salloum, AK; Shasha, N; Stewart, K; Youhanna, S; Zalloua, PA | 1 |
Cho, DY; Kim, BT; Kim, KM; Kim, KN; Lee, DJ | 1 |
Celik, A; Celikyay, ZR; Ceyhan, K; Damar, IH; Erkorkmaz, U; Kadi, H; Koc, F; Ozcetin, M; Sogut, E; Yerli, Y | 1 |
Anglés-Cano, E; Baños-González, MA; Cardoso-Saldaña, G; de la Peña-Díaz, A; González-Pacheco, H; Martínez-Ríos, MA; Peña-Duque, MA; Valente-Acosta, B | 1 |
Jakubowski, H; Perła-Kaján, J | 1 |
Abdessalem, S; Feki, M; Jemaa, R; Kaabachi, N; Kallel, A; Mechmeche, R; Mourali, MS; Sediri, Y | 1 |
Barutcuoğlu, B; Bayındır, O; Işıklar, OO; Kabaroğlu, C; Mutaf, I; Özmen, D; Uluer, H; Zoghi, M | 1 |
Ankrah, A; Buscombe, J; Sathekge, MM | 1 |
Kotamraju, S; Kutala, VK; Lakshmi, SV; Naushad, SM; Rao, DS; Reddy, CA; Saumya, K | 1 |
Funakubo Asanuma, Y | 1 |
Acosta, AM; Cisternas, M; Gutiérrez, MA; Jacobelli, S; Klaassen, J | 1 |
Karthikeyan, G; Prabhakaran, D; Reddy, KS | 1 |
Beaty, TH; Jee, SH; Kim, HK; Park, JY; Shim, WH; Song, KS; Suh, I; Won, SY | 1 |
Anderson, JL; Bair, TL; Carlquist, JF; Habashi, J; Hart, NI; Horne, BD; Jones, SK; Muhlestein, JB | 1 |
Karikas, GA; Papakonstantinou, E; Schulpis, KH | 1 |
Bølling, S; Djurovic, S; Os, A; Os, I; Sandset, PM; Seljeflot, I; Westheim, A | 1 |
Ambrose, JA; Bilianou, HI; DeVoe, MC; Fakiolas, CN; Foussas, SG; Manousakis, SJ; Olympios, CD; Papadaki, OA; Pissimissis, EG; Stefanidis, AS; Zairis, MN | 1 |
Baumann, G; Stangl, K; Stangl, V | 1 |
Adachi, K; Ishihara, S; Kinoshita, Y; Miyaoka, Y; Takashima, T; Yoshino, N; Yuki, T | 1 |
Burke, AP; Fink, L; Fonseca, V; Kolodgie, F; Virmani, R; Zieske, A | 1 |
Dietmar Glogar, H; Huber, K; Mehrabi, MR; Morgan, A; Serbecic, N; Tamaddon, F; Ullrich, R; Wild, T; Wojta, J | 1 |
Diaz-Arrastia, R; Frol, AB; Rogers, JD; Sanchez-Saffon, A | 1 |
Kumar, AV; Lokhandwala, Y | 1 |
Ramachandran, A; Sathyamurthy, I; Satyavani, K; Sivasankari, S; Snehalatha, C; Viswanathan, V | 1 |
Auer, J; Berent, R; Eber, B; Lassnig, E; Rammer, M; Weber, T | 1 |
Cevik, C; Göldeli, E; Güneri, S; Savaş, S; Soysal, D; Sözmen, E; Susam, I | 1 |
Prichard, S | 1 |
Beddhu, S; Herzog, CA; Logar, CM | 1 |
Chmiel, G; Czarnecka, D; Drozdz, M; Gozdecka, H; Kowalczyk-Michałek, M; Kraśniak, A; Małczak, J; Miłkowski, A; Moskal, K; Podwysocki, A; Sułowicz, W; Sydor, A; Szczeklik, A; Szmigielski, M; Wiecek, A; Zabawa-Hołyś, S | 1 |
Imai, Y; Nagai, R | 1 |
Baumgartner, RN; Garry, PJ; Koehler, KM; Lindeman, RD; Romero, LJ; Yau, CL | 1 |
Cavuşoglu, E | 1 |
Jukema, JW; Liem, A; Reynierse-Buitenwerf, GH; van Veldhuisen, DJ; Zwinderman, AH | 1 |
Acartürk, E; Bozkurt, A; Cayli, M; Toyaksi, H; Tuli, A | 1 |
Sobczak, AJ | 1 |
Andel, M; Hyánek, J; Janosíková, B; Kahleová, R; Kocmanová, D; Kozich, V; Kraml, P; Krijt, J; Krupková, L; Pavlíková, M; Veselá, K; Vítová, A; Zvárová, J | 1 |
Aro, A | 1 |
Galar, M; Głowińska, B; Koput, A; Urban, M | 1 |
Allenberg, JR; Darius, H; Diehm, C; Haberl, R; Lange, S; Pittrow, D; Schuster, A; Tepohl, HG; Trampisch, HJ | 1 |
Andreassi, MG; Biagini, A; Botto, N; Cocci, F; Colombo, MG; Manfredi, S; Masetti, S; Rizza, A; Storti, S | 1 |
Ben-Ami, S; Doolman, R; Eldar, M; Freimark, D; Goldenberg, I; Hod, H; Leor, J; Matetzky, S; Novikov, I | 1 |
Al-Habboubi, H; Almawi, WY; Ameen, G; Tamim, H | 1 |
Aranda, JM; Cleeton, TS; Hill, JA; Schofield, RS; Walker, TC; Wessel, TR | 1 |
Cole, DE; Delgado, DH; Miriuka, SG; Rao, V; Ross, HJ | 1 |
Chotkowska, E; Dzielińska, Z; Gaździk, D; Janas, J; Kadziela, J; Piotrowski, W; Ruzyłło, W; Szperl, M | 1 |
Braun, S; Burghartz, M; Kastrati, A; Koch, W; Kölling, K; Lengnick, H; Mehilli, J; Ndrepepa, G; Schömig, A | 1 |
Bharadwaj, RP; Dwivedi, RN; Gupta, OK; Narain, VS; Puri, A; Singh, S | 1 |
Aso, Y; Okumura, K | 1 |
Bertrais, S; Castetbon, K; de Bree, A; Galan, P; Hercberg, S; Mennen, L; Potier de Courcy, G; Preziozi, P | 1 |
Sela, BA; Tanne, D | 1 |
Gauthier, GM; Keevil, JG; McBride, PE | 1 |
Gill, JM; Hale, W; Hecox, K; Mackler, L | 1 |
Gurwitz, D; Habano, W; Itoh, C; Nakai, K | 1 |
Rauwerda, JA; Stehouwer, CD; Twisk, JW; van Campen, CM; van Engeland, MI; Vermeulen, EG; Visser, FC | 1 |
Handa, S; Homma, Y; Yamaguchi, H | 1 |
Cheng, CH; Chung, LJ; Huang, MC; Huang, YC; Lee, BJ; Lin, KL; Su, KH | 1 |
Cheng, J; Guo, H; Lee, JD; Shan, J; Ueda, T; Wang, J | 1 |
Frick, MH; Humphries, SE; Kesäniemi, YA; Nieminen, MS; Pasternack, A; Syvänne, M; Taskinen, MR; Turpeinen, U; Whittall, RA | 1 |
Frohlich, J; Genest, J; Steiner, G | 1 |
Gegenhuber, A; Haltmayer, M; Mueller, T; Poelz, W | 1 |
Moyad, MA | 1 |
Braun, S; Kastrati, A; Koch, W; Kölling, K; Mehilli, J; Ndrepepa, G; Schömig, A | 3 |
Kowalska, I; Lewczuk, A; Mroczko, B; Musiał, W; Prokop, J; Sawicki, R; Skibińska, E | 1 |
Aikawa, M; Kobayashi, H; Kobori, Y; Matsuoka, O; Shindo, N; Takazawa, K; Tanaka, N; Teramoto, T; Yamashina, A | 1 |
Chrysohoou, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C | 1 |
Barghash, AA; Barghash, NA; El Dine, R; Elewa, SM; Hamdi, EA | 1 |
Hofmann, T | 1 |
Black, MJ; Buxton, BF; Hare, DL; Zulli, A | 1 |
Adachi, T; Morishita, T; Nakashima, Y; Nihei, S; Okazaki, M; Ozumi, K; Tasaki, H; Tsutsui, M; Yamashita, K | 1 |
Afrasyap, L; Oztürk, G | 1 |
Choumerianou, D; Chrysohoou, C; Dedoussis, GV; Panagiotakos, DB; Pitsavos, C; Stefanadis, C; Zampelas, A | 1 |
Chen, JW; Leu, HB; Lin, CP; Lin, WT; Wu, TC | 1 |
Jołda-Mydłowska, B | 1 |
Cheng, J; Geshi, T; Guo, H; Lee, JD; Toyoda, K; Ueda, T; Xing, Y | 1 |
Mao, JM; Wang, G; Wang, X; Zhang, FC | 1 |
Darioli, R; Mathez, Ch; Trueb, L; Waeber, G | 1 |
Bedi, GK; Garg, G; Gupta, M; Kaur, K; Sharma, P; Vij, A | 1 |
Klevay, LM | 1 |
Cieslinski, A; Jakubowski, H; Lacinski, M; Skorupski, W; Sokolowska, J; Trzeciak, WH | 1 |
Stanger, O | 1 |
Jakubowski, H; Jankowski, M; Padjas, A; Szczeklik, A; Twardowska, M; Undas, A | 1 |
Aydemir, S; Borazan, A; Sert, M; Yilmaz, A | 1 |
Kremastinos, DT; Kyriakides, ZS; Sbarouni, E | 1 |
Bertolini, S; Cortese, C; Federici, G; Gnasso, A; Irace, C; Liberatoscioli, L; Mannucci, L; Pastore, A; Pisciotta, L | 1 |
Superko, HR | 2 |
Bokhari, SW; Bokhari, ZW; Faxon, DP; Lee, DW; Zell, JA | 1 |
Chen, Z; Li, CS; Liu, XF; Pang, BS; Xia, CQ; Zhang, J | 1 |
Chang, HW; Chen, CJ; Chua, S; Hang, CL; Wu, CJ; Yang, CH; Yip, HK | 1 |
Aydin, S; Curgunlu, A; Erdine, S; Ertürk, N; Karter, Y; Kutlu, A; Oztürk, E; Simsek, G; Uzun, H; Vehid, S | 1 |
Aguadé-Bruix, S; Alvarez-Sabín, J; Arenillas, JF; Candell-Riera, J; Castell-Conesa, J; Chacón, P; de León, G; Molina, CA; Montaner, J; Romero-Farina, G | 1 |
Chai, H; Chen, C; Lin, PH; Lumsden, AB; Yao, Q; Zhou, W | 1 |
Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
Misita, CP; Moll, S; Sturm, AC; Varga, EA | 1 |
Chi, HS; Huh, HJ; Jang, S; Park, CJ; Shim, EH | 1 |
Aziz, DC; Blumenthal, RS; Budoff, MJ; Nasir, K; Park, R; Rasouli, ML | 1 |
Gottsäter, A; Hultberg, B; Jonasson, T; Ohlin, AK; Ohlin, H | 1 |
Dionyssiou-Asteriou, A; Faviou, E; Nounopoulos, C; Vourli, G; Zachari, A | 1 |
Basar, N; Bicer, A; Erbay, AR; Sahin, O; Turhan, H; Yasar, AS; Yetkin, E | 1 |
Chen, C; Chua, WC; El Oakley, RM; Kah, TL; McLachlan, CS; Wong, PT | 1 |
Assmann, G; Cullen, P; Schulte, H | 1 |
Baltar, VT; Batlouni, M; Bertolami, MC; Gravina-Taddei, CF; Salvarini, NA; Sarteschi, C; Sousa, JE | 1 |
Bukowska, H; Honczarenko, K; Jastrzebska, M; Mierzecki, A; Millo, B; Torbus-Lisiecka, B | 1 |
Bowron, A; Scott, J; Stansbie, D | 1 |
Adjalla, CE; Candito, M; Gibelin, P; Gueánt, JL; Guéant-Rodriguez, RM; Herbeth, B; Juilliére, Y; Van Obberghen, E | 1 |
Binder, L; Budde, T; Dobos, GJ; Kannenberg, F; Knoblauch, NT; Lehmann, N; Michalsen, A; Moebus, S; Pithan, C | 1 |
Fujioka, T; Kadota, J; Tamura, A | 1 |
Caliskan, M; Erdogan, D; Gullu, H; Muderrisoglu, H; Ozcimen, EE; Tok, D; Topcu, S; Uckuyu, A; Yildirir, A; Zeyneloglu, H | 1 |
Ozdemir, R; Sezgin, AT; Sezgin, N; Topal, E; Yesilada, E; Yologlu, S | 1 |
Chan, JB; Chen, CP; Eikelboom, JW; Hankey, GJ; Ho, GY; Tan, SL; Wong, CR | 1 |
Spence, JD | 1 |
Al-Fakhri, N; Bdeir, K; Chavakis, T; Economopoulou, M; Gahmberg, CG; Ihanus, E; Isermann, B; Koschinsky, ML; Nawroth, PP; Orlova, VV; Preissner, KT; Sotiriou, SN | 1 |
Bailey, KR; Bielak, LF; Kardia, SL; Kullo, IJ; Li, G; Peyser, PA; Sheedy, PF; Turner, ST | 1 |
Allami, A; Bendriss, A; Benjouad, A; Benkouka, F; Bennouar, N; Benomar, A; Benomar, M; Carrié, A; Coiffard, AS; Fellati, S; Guedira, A; Kadiri, N; Laraqui, A; Raisonnier, A; Srairi, JE | 1 |
Andican, G; Burçak, G; Civelek, S; Demir, AS; Domaniç, N; Gelişgen, R; Ural, D; Vural, VA | 1 |
Brozek, J; Jakubowski, H; Jankowski, M; Siudak, Z; Szczeklik, A; Undas, A | 1 |
Bukiia, TSh; Chaava, MM; Gogokhia, NA | 1 |
Burlina, A; Cesari, M; Maiolino, G; Pedon, L; Pessina, AC; Rossi, GP; Seccia, TM; Sticchi, D; Zanchetta, M; Zavattiero, S | 1 |
Bydlowski, SP; Chagas, AC; Chamone, DA; da Luz, PL; Faria-Neto, JR; Lemos Neto, PA; Ramirez, JA | 1 |
Huber, K; Jordanova, N; Maurer, G; Niessner, A; Nikfardjam, M; Schreiber, W; Speidl, WS; Wojta, J; Zeiner, A; Zorn, G | 1 |
Elkind, MS | 1 |
Chang, SH; Hsieh, IC; Hsu, SY; Hung, KC; Wen, MS | 1 |
Addad, F; Chauffert, M; Chevenne, D; Farhat, MB; Gerhardt, M; Kerkeni, M; Maaroufi, K; Miled, A; Myara, A; Trivin, F | 1 |
Enli, Y; Evrengul, H; Kaftan, A; Kilic, M; Kuru, O; Seleci, D; Tanriverdi, H; Tanriverdi, S | 1 |
Gazdzik, D; Janas, J; Pajak, A; Rywik, S; Sygnowska, E; Waśkiewicz, A | 1 |
Chander, A; Cron, RQ; Cucchiara, AJ; Flagg, SD; Gehrie, E; Genin, A; Kealey, C; Morthala, S; Nackos, E; Scalzi, LV; Van Dyke, AL; Von Feldt, JM; Whitehead, AS | 1 |
Celik, A; Cicek, HK; Davutoglu, V; Yilmaz, N | 1 |
Hiramoto, JS; Lane, JS; Lane, KT; Messina, LM; Vittinghoff, E | 1 |
Chan, L; Durante, W; Gaubatz, J; Hui, R; Jiang, X; Li, Z; Liao, D; Pownall, HJ; Schafer, AI; Tan, H; Wang, H; Yang, F; Yang, X | 1 |
Antoniades, C; Cai, S; Channon, KM; de Bono, J; Lee, J; Leeson, P; Neubauer, S; Pillai, R; Ratnatunga, C; Refsum, H; Shirodaria, C; Warrick, N | 1 |
Alharethi, R; Anderson, JL; Bair, TL; Carlquist, JF; Horne, BD; Kfoury, AG; May, HT; Muhlestein, JB; Renlund, DG; Reyna, SP | 1 |
Bozzini, C; Corrocher, R; Faccini, G; Friso, S; Girelli, D; Guarini, P; Martinelli, N; Olivieri, O; Pizzolo, F; Trabetti, E | 1 |
Imren, E; Ozkan, Y; Simşek, B; Torun, M; Yardim-Akaydin, S | 1 |
Darvish, S; Davoodi, G; Fallah, N; Fallahi, F; Karimi, A; Mahmoodian, M; Sadeghian, S; Salarifar, M | 1 |
Chai, H; Chen, C; Courson, A; Lin, PH; Lumsden, AB; Yao, Q; Zhou, W | 1 |
Alekel, DL; Engelman, HM; Hanson, LN; Kohut, ML; Reddy, MB; Schalinske, KL | 1 |
Enneifer, M; Feki, M; Kaabachi, N; Mebazaa, A; Mechmeche, R; Mourali, S; Omar, S; Sanhaji, H; Souissi, M | 1 |
Ilhan, N; Ozbay, Y; Seckin, D | 1 |
Bode-Böger, SM; Dubiel, JS; Huszno, B; Kawecka-Jaszcz, K; Klecha, A; Martens-Lobenhoffer, J; Stochmal, A; Stochmal, E; Surdacki, A; Szurkowska, M; Szybiński, Z | 1 |
Bozzini, C; Corrocher, R; Faccini, G; Friso, S; Girelli, D; Guarini, P; Lotto, V; Martinelli, N; Mazzucco, A; Olivieri, O; Pignatti, PF; Pizzolo, F; Tenuti, I; Trabetti, E; Villa, G | 1 |
Cavalcanti, Mdo S; D'Almeida, V; dos Santos, JE; Fonseca, RA; Hotta, JK; Muniz, MT; Sampaio, CA; Siqueira, ER | 1 |
Allen, RA; Dunn, ST; Eichner, JE; Kebert, CB; Moore, WE; Schechter, E; Vogel, S; Yaoi, T | 1 |
Enli, Y; Evrengul, H; Kaftan, HA; Karabulut, N; Kuru, O; Seleci, D; Tanriverdi, H; Tanriverdi, S; Tuzun, N | 1 |
Carluccio, M; Cattaneo, M; Danek, G; De Caterina, R; Diviacco, S; Fioretti, P; Gregori, D; Lazzerini, G; Lombardi, R; Pilotto, L; Quadrifoglio, F; Vanuzzo, D | 1 |
Demkow, M; Dzielińska, Z; Florczak, E; Janas, J; Januszewicz, A; Januszewicz, M; Kadziela, J; Makowiecka-Cieśla, M; Naruszewicz, M; Nowicka, G; Prejbisz, A; Ruzyłło, W; Zieliński, T | 1 |
Dei Cas, L; Fiorina, C; Metra, M; Nodari, S; Vizzardi, E | 1 |
Głuszek, J; Pawlak, AL; Strauss, E; Supiński, W | 1 |
Glowacki, R; Kolarz, M; Kopec, G; Placzkiewicz-Jankowska, E; Tracz, W; Undas, A | 1 |
Stühlinger, M | 1 |
Geshi, T; Guo, H; Lee, JD; Toyoda, K; Ueda, T; Uzui, H; Wang, P; Yue, H | 1 |
Carvalho, Md; da Fonseca Neto, CP; Fernandes, AP; Garcia, JC; Lima, LM; Loures-Vale, AA; Saad, JA; Sabino, Ade P; Sousa, MO | 1 |
Jacobs, DR; Kori, S; Lutsey, PL; Mayer-Davis, E; Shea, S; Steffen, LM; Szklo, M; Tracy, R | 1 |
Son, YJ | 1 |
Abdelmouttaleb, I; Aliot, E; Danchin, N; Guéant, JL; Guéant-Rodriguez, RM; Herbeth, B; Juillière, Y; Nippert, M | 1 |
Barr, RG; Bertoni, AG; Jacobs, DR; Jenny, NS; Nettleton, JA; Schulze, MB; Steffen, LM | 1 |
Cabrera-Bueno, F; de Teresa-Galván, E; Espinosa-Caliani, S; García-Pinilla, JM; Gómez-Doblas, JJ; Jiménez-Navarro, M; Reyes-Engel, A | 1 |
Bakken, AM; Bleie, Ø; Grundt, H; Nilsen, DW; Nordrehaug, JE; Nygård, OK; Refsum, H; Semb, AG; Ueland, PM; Vollset, SE | 1 |
Jiang, SL; Ni, M; Zhang, XH; Zhang, Y | 1 |
Ferro, A; Jackson, G; O'Kane, PD | 1 |
Alina, AR; Bondar', IA; Pechkovskiĭ, EV; Pikalov, IV | 1 |
Blum, A; Blum, N; Eizenberg, MM; Hijazi, I | 1 |
Drwiła, R; Plicner, D; Sadowski, J; Stepień, E; Undas, A | 1 |
Moriatis, M; Naidoo, D; Salonikas, C; Sim, AS; Wang, J; Wang, XL; Wilcken, DE | 1 |
D'Almeida, V; de Carvalho, JF; de Souza, AW; Noguti, MA; Sato, EI; Silva, NP | 1 |
Amini, AL; Amiri, M; Jafari, SM; Nabipour, I; Pazoki, R; Riazi, A; Sanjdideh, Z; Shafeiae, E; Vahdat, K | 1 |
Barsacchi, R; Barsanti, L; Battaglia, D; Kusmic, C; Palombo, C; Paolicchi, A; Parodi, O; Taddei, MC; Vesentini, N | 1 |
Kochmański, M; Stasiakowska-Badura, E | 1 |
Ilhan, N; Kaman, D; Kucuksu, M; Ozbay, Y | 1 |
Alam, MA; Chauhan, SS; Husain, SA; Kabra, M; Narang, R; Vasisht, S | 1 |
Bang, H; Chambless, LE; Howard, VJ; Pettigrew, LC; Toole, JF | 1 |
Chen, YJ; Gau, CS; Hwang, JJ; Lin, YH; Lin, YL; Pao, KY; Tsai, IJ; Tsai, WS; Wu, VC; Yang, WS | 1 |
Abboud, N; Addad, F; Almawi, WY; Amin, H; Ghazouani, L; Mahjoub, T; Mtiraoui, N; Zammiti, W | 1 |
Bolca, O; Cakmak, N; Nurkalem, Z; Onturk, E; Sahin, S; Sayar, N; Tangurek, B; Yilmaz, H; Yilmaz, M | 1 |
Chen, JW; Chen, YH; Huang, SL; Leu, HB; Lin, CP; Lin, WT; Liu, TZ | 1 |
Evered, L; Jamrozik, K; McCutcheon, C; Scott, DA; Silbert, B | 1 |
Cheng, CH; Chou, MC; Ho, CC; Huang, YC; Liaw, YP; Lin, PT; Tsai, TP | 1 |
Brehm, A; Brión, M; Carracedo, A; Freitas, AI; Guerra, G; Mendonça, I; Reis, RP | 1 |
Atar, I; Aydinalp, A; Bozbaş, H; Eroğlu, S; Korkmaz, ME; Müderrisoğlu, H; Ozin, B; Pirat, B; Ulus, T; Yildirir, A | 1 |
Dippel, EJ; Harb, H; Jerin, M; Kapalis, M; Reddy, M; Shammas, NW; Toth, PP | 1 |
Bernat, R; Ferencak, G; Grsković, B; Marinković, N; Pasalić, D; Stavljenić-Rukavina, A | 1 |
Geisel, J; Hentschel, B; Herrmann, W; Kuntze, T; Rassoul, F; Richter, V | 1 |
Kiani, AN; Magder, L; Petri, M | 1 |
Green, R; Gupta, A; Kottke-Marchant, K; Mayer, EL; Miller, DP; Nissen, SE; Robinson, K; Savon, SR; Selhub, J; van Lente, F | 1 |
Frohlich, JJ | 1 |
Kang, SS; Passen, EL; Ruggie, N; Sora, H; Wong, PW | 1 |
Jacobsen, DW; Mayer, EL; Robinson, K | 1 |
Banga, JD; de Groot, E; de Klerk, JB; de Valk, HW; Duran, M; Haas, FJ; Meuwissen, OJ; Poll-The, BT; Rolland, MO; Smeitink, JA; van der Griend, R; van Eeden, MK; Wittebol-Post, D | 1 |
Chan, CF; Cheng, SK; Lolin, YI; Masarei, JR; Pang, CP; Sanderson, JE; Woo, KS | 1 |
Abbate, R; Gensini, GF; Micheli, S; Prisco, D | 1 |
Grobbee, DE; Kok, FJ; Kruyssen, DA; Refsum, H; Schouten, EG; Ueland, PM; Verhoef, P; Witteman, JC | 1 |
Blom, HJ; Kluijtmans, LA; Kok, FJ; Kruyssen, DA; Refsum, H; Ueland, PM; Verhoef, P | 1 |
Ankri, A; Benzidia, R; Blacher, J; Chadefaux-Vekemans, B; Drobinski, G; Kamoun, P; Montalescot, G; Philippe, F; Thomas, D | 1 |
Nehler, MR; Porter, JM; Taylor, LM | 1 |
Blanco Vaca, F; Córdoba Porras, A; González Sastre, F | 1 |
Nygård, O; Refsum, H; Ueland, PM; Vollset, SE | 1 |
Clonts, B; Mujumdar, VS; Parker, JL; Smiley, LM; Tyagi, SC | 1 |
Kok, FJ; Siri, PW; Verhoef, P | 1 |
Moneta, GL; Porter, JM; Schuff, RA; Sexton, GJ; Taylor, LM | 1 |
Lonn, EM; Yusuf, S | 1 |
Appel, LJ; Maguire, MG; Miller, ER; Selhub, J; Stolzenberg-Solomon, RZ | 1 |
Asazuma, K; Eguchi, K; Kosaka, S; Miyamori, I; Oida, K; Okada, E; Tada, H; Takahashi, S; Tohda, G | 1 |
Gardemann, A; Haberbosch, W; Hehrlein, FW; Katz, N; Philipp, M; Tillmanns, H; Weidemann, H | 1 |
Evans, A; Gey, KF; McCrum, EE; McMaster, D; Roxborough, HE; Woodside, JV; Yarnell, JW; Young, IS | 1 |
Burgess, ED; Hyndman, ME; Manns, BJ; Parsons, HG; Schaefer, JP; Scott-Douglas, NW | 1 |
Assmann, G; Breithardt, G; Cullen, P; Erren, M; Fobker, M; Junker, R; Kerber, S; Kropf, J; Reinecke, H; Schulte, H; Schurek, JO | 1 |
Pasceri, V; Willerson, JT | 1 |
Green, DJ; Maiorana, A; O'Driscoll, JG; Scrimgeour, NB; Taylor, RR; Weerasooriya, R | 1 |
Haraki, T; Inazu, A; Kajinami, K; Kawashiri, M; Koizumi, J; Mabuchi, H; Nohara, A; Takegoshi, T; Yagi, K | 1 |
Daniels, SR; Jacobsen, DW; Khoury, P; Morrison, JA; Robinson, K; Sprecher, DL | 1 |
Barnabei, VM; Hsia, J; Phillips, TM | 1 |
Allain, P; Benoit, C; Furber, A; Geslin, P; Le Bouil, A; Merheb, M; Tadéi, A | 1 |
Challier, B; Chalopin, JM; Ducloux, D; Gibey, R; Motte, G | 1 |
Bostom, AG | 2 |
Oosterhof, J; Wang, XL | 1 |
Brattström, L; Hultberg, B; Landgren, F; Nielsen, NE; Swahn, E | 1 |
Robinson, K; Seshadri, N | 1 |
Altieri, PI; Banch, H; Cruz, D; Escobales, N; Rivera, C; Rodríguez, JF; Rodríguez, JL | 1 |
Chao, TH; Chen, JH; Chen, TY; Li, YH; Lin, LJ; Tsai, LM; Tsai, WC | 1 |
Andrejak, M; Iannetta Peltier, MC; Lesbre, JP; Peltier, M; Tribouilloy, CM; Trojette, F | 1 |
Kluijtmans, LA; Whitehead, AS | 1 |
Feuerstein, IM; Hunt, ME; O'Malley, PG; Taylor, AJ; Vernalis, MN | 1 |
Bhuripanyo, K; Chotinaiwattarakul, C; Hongvisitkul, C; Kangkagate, C; Krittayaphong, R; Leowattana, W; Mahanonda, N; Pokum, S; Wansanit, K | 1 |
Abrams, J; Chai, AU | 1 |
Parhofer, KG | 1 |
Auer, J; Berent, R; Eber, B; Lassnig, E; Weber, T | 1 |
Dabrowski, M; Deptuch, T; Dzielińska, Z; Kadziela, J; Kruk, M; Piotrowski, W; Przyłuski, J; Ruzyłło, W; Sitkiewicz, D | 1 |
Hayakawa, T; Kamiya, H; Kondo, J; Kosokabe, T; Matsui, H; Mukawa, H; Okumura, K; Sone, T; Suzuki, T; Tomida, T; Tsuboi, H | 1 |
Bostom, AG; Jacques, PF; Liaugaudas, G; Rosenberg, IH; Selhub, J | 1 |
Haks, K; Schouten, EG; van den Brandhof, WE; Verhoef, P | 1 |
Chen, J; Cheng, L; Li, Y; Zhang, I | 1 |
Austin, RC; Bentzon, J; Danielsen, CC; Falk, E; Møller, J; Ravn, HB; Zhou, J | 1 |
Graf, S; Hornykewycz, S; Huber, K; Huber-Beckmann, R; Nikfardjam, M; Wojta, J; Zorn, G | 1 |
Aksoyek, S; Haznedaroglu, I; Kabakci, G; Kes, S; Kirazli, S; Oto, A; Ovunc, K; Ozmen, F; Sinici, I; Tokgozoglu, SL; Yildirir, A | 1 |
Adkins, RH; Bauman, WA; Herbert, V; Kemp, B; Spungen, AM; Waters, RL | 1 |
Dai, C; Zhang, G | 1 |
Bacchi-Reggiani, L; Branzi, A; Falchetti, E; Grigioni, F; Magelli, C; Magnani, G; Mantovani, V; Potena, L; Sassi, S; Sorbello, S; Viggiani, M | 1 |
SoRelle, R | 1 |
Doshi, SN; Durrant, HJ; Goodfellow, J; Lewis, MJ; McDowell, IF; Moat, SJ; Payne, N | 1 |
Födinger, M; Sunder-Plassmann, G | 1 |
Pogach, L | 1 |
Florczak, K; Penckofer, S; Schwertz, D | 1 |
Farmer, JA; Torre-Amione, G | 1 |
Goodson, N | 1 |
Bostom, AG; Jacques, PF; Liaugaudas, G; Rogers, G; Rosenberg, IH; Selhub, J | 1 |
Meinitzer, A; Rehak, P; Rigler, B; Semmelrock, HJ; Stanger, OH; Tiran, A; Tiran, B | 1 |
Clearfield, M; Cook, TJ; Downs, JR; Gotto, AM; Pradhan, AD; Ridker, PM; Shih, J; Weis, SE | 1 |
Erdei, F; Katona, A; Kondacs, A; Mark, L; Markizay, J | 1 |
Fujioka, T; Nasu, M; Tamura, A | 1 |
Choi, SW; Hong, MK; Kang, DH; Kim, JJ; Lee, CW; Park, SJ; Park, SW; Song, JK; Song, JM | 1 |
Abdel-Raheem, MM; Danielson, BD; Hebert, B; Koka, VK; Potti, A | 1 |
Corrocher, R; Faccini, G; Friso, S; Girelli, D; Martinelli, N; Olivieri, O; Pignatti, PF; Stranieri, C; Tinazzi, E; Trabetti, E | 1 |
Acevedo, M; Kottke-Marchant, K; Pearce, GL; Sprecher, DL | 1 |
Bialkowska, M; McCully, KS; Olszewski, AJ; Rudnicki, S; Szostak, WB | 1 |
49 review(s) available for homocysteine and Coronary Artery Disease
Article | Year |
---|---|
Aberrant DNA methylation and miRNAs in coronary artery diseases and stroke: a systematic review.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Databases, Factual; Databases, Genetic; DNA Methylation; Genome-Wide Association Study; Homocysteine; Humans; Lipid Metabolism; MicroRNAs; Nitric Oxide; Stroke | 2020 |
No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study.
Topics: Coronary Artery Disease; Genome-Wide Association Study; Homocysteine; Humans; Mendelian Randomization Analysis; Myocardial Infarction; Polymorphism, Single Nucleotide | 2021 |
The role of DNA methylation in coronary artery disease.
Topics: Alu Elements; Animals; Coronary Artery Disease; DNA Methylation; Epigenesis, Genetic; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Long Interspersed Nucleotide Elements; Male; Sequence Analysis, DNA | 2018 |
Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease.
Topics: Coronary Artery Disease; Genes; Genetic Loci; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Polymorphism, Genetic; Risk Factors | 2013 |
The effect of homocysteine-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: a meta-analysis of randomized controlled trials.
Topics: Aged; Atherosclerosis; Brachial Artery; Coronary Artery Disease; Dietary Supplements; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Vasodilation | 2014 |
Genome-wide association study of selenium concentrations.
Topics: Coronary Artery Disease; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Genotyping Techniques; Homocysteine; Humans; Nails; Polymorphism, Single Nucleotide; Selenium; Selenoproteins; Thioredoxin Reductase 1 | 2015 |
Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: A meta-analysis.
Topics: Adult; Asian People; China; Coronary Artery Disease; Genetic Predisposition to Disease; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Publication Bias; Young Adult | 2015 |
Association between eNOS polymorphisms and risk of coronary artery disease in a Korean population: a meta-analysis.
Topics: Aged; Alleles; Asian People; Case-Control Studies; Comorbidity; Coronary Artery Disease; Female; Folic Acid; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Haplotypes; Homocysteine; Humans; Linkage Disequilibrium; Male; Middle Aged; Nitric Oxide Synthase Type III; Odds Ratio; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Republic of Korea; Risk; Risk Factors | 2015 |
Cardiac biomarkers and chronic renal diseases.
Topics: Animals; Arginine; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Disease Progression; Homocysteine; Humans; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Troponin | 2008 |
Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
Topics: Clinical Trials as Topic; Coronary Artery Disease; Folic Acid; Food, Fortified; Homocysteine; Humans; Oxidation-Reduction; Vitamin B Complex; Vitamins | 2009 |
Cardiac biomarkers in the diagnosis, prognosis and management of coronary artery disease: a primer for internists.
Topics: Biomarkers; C-Reactive Protein; Cardiology; Coronary Artery Disease; Disease Management; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, HDL; Lipoproteins, LDL; Matrix Metalloproteinase 9; Natriuretic Peptide, Brain; Peroxidase | 2010 |
Paraoxonase 1 and homocysteine metabolism.
Topics: Alzheimer Disease; Animals; Aryldialkylphosphatase; Atherosclerosis; Coronary Artery Disease; Diabetes Mellitus; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Lipoproteins, HDL; Mice; Oxidative Stress; Stroke | 2012 |
[Accelerated atherosclerosis and inflammation in systemic lupus erythematosus].
Topics: C-Reactive Protein; Coronary Artery Disease; Cytokines; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Lipoprotein(a); Lupus Erythematosus, Systemic; Male; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sex Factors | 2012 |
Plasma homocysteine levels and cardiovascular risk in Indians.
Topics: Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; India; Risk Factors | 2002 |
Coronary atherogenic risk factors in women.
Topics: Blood Coagulation Factors; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Complications; Exercise; Female; Homocysteine; Humans; Hyperlipidemias; Hypertension; Lipoprotein(a); Menopause; Obesity; Pedigree; Risk Factors; Smoking; Stress, Psychological; Triglycerides | 2002 |
Risk factors for coronary artery disease in patients with renal failure.
Topics: Calcium; Coronary Artery Disease; Diabetes Mellitus; Homocysteine; Humans; Hyperlipidemias; Hypertension; Inflammation; Nitric Oxide; Oxidants; Phosphates; Renal Dialysis; Renal Insufficiency; Risk Factors; Smoking | 2003 |
Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations.
Topics: Antihypertensive Agents; Calcium; Coronary Artery Disease; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Kidney Transplantation; Lipid Metabolism; Myocardial Revascularization; Nutritional Physiological Phenomena; Oxidative Stress; Parathyroid Hormone; Renal Insufficiency; Risk Factors; Vitamin D | 2003 |
[New biochemical and genetic risk factors for coronary artery diseases].
Topics: Aryldialkylphosphatase; Biomarkers; Blood Coagulation Factors; C-Reactive Protein; Cholesterol, HDL; Coronary Artery Disease; Esterases; Fibrinogen; Homocysteine; Humans; Insulin Resistance; Lipoprotein(a); Lipoproteins, LDL; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Renin-Angiotensin System; Risk Factors | 2003 |
The effects of tobacco smoke on the homocysteine level--a risk factor of atherosclerosis.
Topics: Coronary Artery Disease; Folic Acid Deficiency; Homocysteine; Humans; Intracranial Arteriosclerosis; Peripheral Vascular Diseases; Risk Factors; Tobacco Use Disorder; Vitamin B 12 Deficiency; Vitamin B 6 Deficiency | 2003 |
[Homocysteine and coronary artery disease].
Topics: Coronary Artery Disease; Dietary Supplements; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2003 |
Hyperhomocysteinemia in heart transplantation: from bench to bedside.
Topics: Coronary Artery Disease; Female; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Point Mutation; Postoperative Complications | 2003 |
The association of homocysteine and coronary artery disease.
Topics: Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2003 |
Clinical inquiries. Is folate supplementation indicated for patients with CAD?
Topics: Coronary Artery Disease; Folic Acid; Hematinics; Homocysteine; Humans; Randomized Controlled Trials as Topic | 2004 |
Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD.
Topics: Clinical Trials as Topic; Coronary Artery Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Methylenetetrahydrofolate Reductase (NADPH2); Point Mutation; Polymorphism, Genetic; Prevalence | 2001 |
Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part II: what do I tell my patients?
Topics: Adult; Age Factors; Aged; Apolipoproteins; Biomarkers; C-Reactive Protein; Calcium; Cardiovascular Diseases; Cholesterol, HDL; Coronary Artery Disease; Health Status; Homocysteine; Humans; Male; Middle Aged; Physician-Patient Relations; Primary Prevention; Risk Assessment; Sensitivity and Specificity; Survival Analysis | 2004 |
[Risk management of coronary artery disease--pharmacological therapy].
Topics: Adrenergic beta-Antagonists; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Drug Therapy, Combination; Homocysteine; Humans; Nitroglycerin; Risk Factors | 2004 |
[Homocysteine as the factor of atherosclerosis risk].
Topics: Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia | 2004 |
Ischemic heart disease as deficiency disease.
Topics: Animals; Aryldialkylphosphatase; Catalysis; Collagen; Coronary Artery Disease; Cross-Linking Reagents; Dietary Supplements; Elastin; Glucose; Heart Diseases; Homocysteine; Humans; Hydrolysis; Lipid Metabolism; Myocardial Ischemia; Vitamins | 2004 |
The potential role of homocysteine in percutaneous coronary interventions (PCI): review of current evidence and plausibility of action.
Topics: Adult; Aged; Angioplasty; Angioplasty, Balloon, Coronary; Animals; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Endothelium, Vascular; Female; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Male; Middle Aged; Models, Biological; Risk; Risk Factors; Vitamin B Complex | 2004 |
Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals.
Topics: Biomarkers; C-Reactive Protein; Cardiac Care Facilities; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Disease Susceptibility; Homocysteine; Humans; Insulin Resistance; Metabolic Diseases | 2003 |
[Coronary artery disease and H. pylori eradication].
Topics: Arteriosclerosis; C-Reactive Protein; Cholesterol, HDL; Coronary Artery Disease; Cytokines; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Inflammation Mediators | 2005 |
Inflammation, atherosclerosis, and stroke.
Topics: Antigens, CD; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Cytokines; Diffusion Magnetic Resonance Imaging; Homocysteine; Humans; Inflammation; Internal Capsule; Intracranial Arteriosclerosis; Risk Factors; Stroke | 2006 |
Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link?
Topics: Coronary Artery Disease; Heart Ventricles; Homocysteine; Humans | 2007 |
New aspects of risk factors for the development of atherosclerosis, including small low-density lipoprotein, homocyst(e)ine, and lipoprotein(a).
Topics: Coronary Artery Disease; Homocysteine; Homocystine; Humans; Lipoprotein(a); Lipoproteins, LDL; Risk Factors | 1995 |
Lipoproteins and homocyst(e)ine as risk factors for atherosclerosis: assessment and treatment.
Topics: Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoprotein(a); Male; Recurrence; Risk Factors | 1995 |
Homocysteine and coronary atherosclerosis.
Topics: Coronary Artery Disease; Folic Acid; Homocysteine; Homocystinuria; Humans; Pyridoxine; Risk Factors; Vitamin B 12 | 1996 |
Menopause and risk of cardiovascular disease.
Topics: Adult; Aged; Animals; Antioxidants; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Coronary Artery Disease; Diet; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Follow-Up Studies; Glucose; Hemostasis; Homocysteine; Humans; Incidence; Lipid Metabolism; Menopause; Middle Aged; Ovary; Risk; Risk Factors; Vitamins | 1996 |
Homocysteinemia as a risk factor for atherosclerosis: a review.
Topics: Arteriosclerosis; Coronary Artery Disease; Disease Progression; Homocysteine; Humans; Hypertension; Risk Factors | 1997 |
[Hyperhomocysteinemia: a new marker of vascular risk: affected vascular areas, its role in the pathogenesis of arteriosclerosis and thrombosis and treatment].
Topics: Adult; Coronary Artery Disease; Coronary Thrombosis; Female; Homocysteine; Homocystinuria; Humans; Male; Methionine; Middle Aged; Peripheral Vascular Diseases; Pregnancy; Thrombophlebitis; Vitamins | 1997 |
Homocysteine and cardiovascular disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Female; Folic Acid; Folic Acid Deficiency; Forecasting; Homocysteine; Humans; Intracranial Arteriosclerosis; Male; Peripheral Vascular Diseases; Prevalence; Risk Factors; Safety; Thromboembolism; Vitamin B 12; Vitamin B 12 Deficiency | 1998 |
Emerging approaches in the prevention of atherosclerotic cardiovascular diseases.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; beta Carotene; Cohort Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Oxidative Stress; Randomized Controlled Trials as Topic; Vitamin E | 1998 |
Homocysteine and coronary heart disease: a review of the current evidence.
Topics: Animals; Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Prospective Studies; Risk Assessment; Sensitivity and Specificity | 1999 |
Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?
Topics: Biomarkers; Coronary Artery Disease; Creatinine; Female; Graft Survival; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2000 |
Homocysteine and coronary risk.
Topics: Age Factors; Clinical Trials as Topic; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Life Style; Male; Risk Factors; Sex Factors | 1999 |
Homocysteine: a new cardiac risk factor?
Topics: Coronary Artery Disease; Coronary Disease; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Risk Factors | 2001 |
[Homocysteine and cardiovascular risk].
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Animals; Arteriosclerosis; Clinical Trials as Topic; Coronary Artery Disease; Disease Models, Animal; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Vitamin B 12 | 2001 |
Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Blood Glucose; Clinical Trials as Topic; Coronary Artery Disease; Diabetes Mellitus, Type 2; Ferritins; Homocysteine; Humans; Oxidative Stress; Reactive Oxygen Species; Vitamin E | 2002 |
Atherosclerosis and inflammation.
Topics: C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Homocysteine; Hot Temperature; Humans; Inflammation; Tumor Necrosis Factor-alpha | 2002 |
Coronary artery disease and rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; C-Reactive Protein; Comorbidity; Coronary Artery Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypertension; Risk Factors; Smoking; Survival Analysis; Survival Rate | 2002 |
45 trial(s) available for homocysteine and Coronary Artery Disease
Article | Year |
---|---|
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease.
Topics: Coronary Artery Disease; Fibrin; Folic Acid; Homocysteine; Humans; Myocardial Infarction; Prognosis; Risk Factors; Thrombosis; Vitamin B 12; Vitamin B Complex | 2022 |
Effects of consuming red furu (fermented bean curd) on serum vitamin B-12, homocysteine and other cardiometabolic risk factors in young healthy volunteers: A randomized controlled trial.
Topics: Adult; Cardiometabolic Risk Factors; Coronary Artery Disease; Female; Healthy Volunteers; Homocysteine; Humans; Male; Phytotherapy; Soy Foods; Vitamin B 12; Young Adult | 2020 |
Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up.
Topics: Aged; C-Reactive Protein; China; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Stents | 2019 |
Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Adult; Aged; Atherosclerosis; Coronary Artery Disease; Coronary Vessels; Dietary Supplements; Disease Progression; Dose-Response Relationship, Drug; Follow-Up Studies; Garlic; Homocysteine; Humans; Male; Middle Aged; Pericardium; Plant Extracts; Risk Factors; Thermometry; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Topics: Adult; Arachidonic Acid; Aspirin; Blood Platelets; Collagen; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Resistance; Female; Homocysteine; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Young Adult | 2013 |
The index and improvement effect of using Danhong injection to patients with atherosclerosis symptoms of coronary heart disease (CHD).
Topics: Aged; Atherosclerosis; C-Reactive Protein; Coronary Artery Disease; Drugs, Chinese Herbal; Homocysteine; Humans; Injections; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments | 2014 |
Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease.
Topics: Aged; Arginine; Arthritis, Rheumatoid; Coronary Artery Disease; Female; Homoarginine; Homocysteine; Humans; Male; Middle Aged; Peripheral Arterial Disease | 2015 |
Intensive statin therapy, used alone or in combination with ezetimibe, improves homocysteine level and lipid peroxidation to a similar degree in patients with coronary artery diseases.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Case-Control Studies; Cholesterol, LDL; Coronary Artery Disease; Drug Therapy, Combination; Ezetimibe; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Male; Middle Aged; Rosuvastatin Calcium | 2016 |
Impact of Homocysteine Level on Long-term Cardiovascular Outcomes in Patients after Coronary Artery Stenting.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Stents; Survival Rate; Young Adult | 2017 |
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
Topics: Aged; Aortic Valve Stenosis; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
The effect of L-arginine and creatine on vascular function and homocysteine metabolism.
Topics: Aged; Arginine; Brachial Artery; Coronary Artery Disease; Creatine; Dietary Supplements; Female; Glycine; Homocysteine; Humans; Hyperemia; Male; Methionine; Middle Aged; Regional Blood Flow; Treatment Outcome; Ultrasonography; Vasodilation | 2009 |
Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Norway; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2010 |
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12.
Topics: Acetylcholine; Adenosine; Aged; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Laser-Doppler Flowmetry; Male; Middle Aged; Time Factors; Vitamin B 12; Vitamin B 6 | 2011 |
Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Coronary Artery Disease; Dietary Supplements; Female; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Male; Malondialdehyde; Patient Dropouts; Superoxide Dismutase; Ubiquinone | 2012 |
Lipoprotein(a) and homocysteine potentiate the risk of coronary artery disease in male subjects.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Homocysteine; Humans; Lipoprotein(a); Logistic Models; Male; Middle Aged; Risk Factors | 2012 |
Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
Topics: Administration, Cutaneous; Age Factors; Aged; Biomarkers; Body Mass Index; C-Peptide; Coronary Artery Disease; E-Selectin; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Severity of Illness Index; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Women's Health | 2002 |
Secondary prevention with folic acid: effects on clinical outcomes.
Topics: Aged; Cholesterol; Coronary Artery Disease; Drug Therapy, Combination; Endothelium, Vascular; Female; Folic Acid; Follow-Up Studies; Hematinics; Homocysteine; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Outcome Assessment, Health Care; Time Factors; Triglycerides | 2003 |
High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy.
Topics: Aged; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Thrombomodulin | 2003 |
Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemi
Topics: Aged; Aged, 80 and over; Coronary Artery Disease; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Female; Folic Acid; Homocysteine; Humans; Intracranial Arteriosclerosis; Ischemia; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Vitamin B 12; Vitamin B 6 | 2003 |
Effect of homocysteine-lowering vitamin treatment on electrocardiography stress tests in a randomized, placebo-controlled trial: comparison between ST-segment changes and Athen QRS-score.
Topics: Coronary Artery Disease; Double-Blind Method; Electrocardiography; Exercise Test; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Vitamin B 6 | 2004 |
Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Folic Acid; Homocysteine; Humans; Male; Mental Recall; Middle Aged; Single-Blind Method; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2004 |
Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis.
Topics: Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Gemfibrozil; Homocysteine; Humans; Hypolipidemic Agents; Male; Methylenetetrahydrofolate Reductase (NADPH2); Triglycerides | 2004 |
Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Fenofibrate; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged | 2004 |
Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; C-Reactive Protein; Coronary Artery Disease; Cross-Sectional Studies; Female; Greece; Homocysteine; Humans; Hypertension; Inflammation Mediators; Male; Middle Aged; Prevalence; Risk Factors; Statistics as Topic; Tumor Necrosis Factor-alpha | 2004 |
The effect of hormone replacement therapy and simvastatin on plasma homocysteine.
Topics: Aged; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Hypercholesterolemia; Hypolipidemic Agents; Medroxyprogesterone; Middle Aged; Simvastatin; Time Factors; Treatment Outcome | 2005 |
Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
Topics: Aged; Biomarkers; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Pyridoxine; Vitamin B 12; Vitamins | 2005 |
Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease.
Topics: Biomarkers; C-Reactive Protein; Coronary Artery Disease; Diet, Mediterranean; Fatty Acids; Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Insulin; Lipids; Male; Middle Aged; Risk Factors | 2006 |
Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.
Topics: Aged; Coronary Artery Disease; Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Ischemic Attack, Transient; Male; Methylenetetrahydrofolate Dehydrogenase (NAD+); Middle Aged; Models, Statistical; Placebos; Polymorphism, Genetic; Regression Analysis; Risk Factors; Singapore; Stroke; Vitamin B 12; Vitamin B 6; Vitamins | 2006 |
Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
Topics: Adult; Aged; Coronary Artery Disease; Female; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Risk Factors; Tissue Plasminogen Activator | 2007 |
Diagnostic value of bilirubin concentrations compared with novel and traditional biomarkers in atherosclerosis with coronary artery disease.
Topics: Atherosclerosis; Bilirubin; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Oxidative Stress; ROC Curve; Sensitivity and Specificity | 2006 |
5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling.
Topics: Acetylcholine; Antioxidants; Atherosclerosis; Biological Availability; Biopterins; Bradykinin; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Homocysteine; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Protein Binding; Superoxides; Tetrahydrofolates | 2006 |
Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women.
Topics: Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Coronary Artery Disease; Double-Blind Method; Female; Ferritins; Folic Acid; Homocysteine; Humans; Iron; Isoflavones; Lipids; Middle Aged; Oxidative Stress; Phytic Acid; Plant Proteins, Dietary; Postmenopause; Regression Analysis; Risk Factors; Soybean Proteins; Transferrin; Vitamin B 12 | 2006 |
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; CD40 Ligand; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Interleukin-6; Male; Middle Aged; Neopterin; Prospective Studies; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2007 |
Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial.
Topics: Aged; Cohort Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Risk; Stroke; Vitamins | 2008 |
Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease.
Topics: Acetylcysteine; Administration, Oral; Aged; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged | 2007 |
Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population.
Topics: Aged; Aging; Antioxidants; Body Mass Index; Coffee; Coronary Artery Disease; Diet Records; Dietary Proteins; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Linear Models; Male; Middle Aged; Vitamins | 1999 |
The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease.
Topics: Adult; Aged; Analysis of Variance; Coronary Artery Disease; Genetic Markers; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prognosis; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index | 1999 |
Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial.
Topics: Adult; Antioxidants; Coronary Artery Disease; Double-Blind Method; Homocysteine; Humans; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Risk Factors; Vitamin B Complex | 1999 |
Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Topics: Arteriosclerosis; Coronary Artery Disease; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors | 1999 |
[Elevated levels of homocysteine in plasma as a risk factor for coronary artery disease].
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Male; Middle Aged; Odds Ratio; Risk Factors; Vitamins | 2000 |
Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting.
Topics: Alleles; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Disease Progression; DNA Mutational Analysis; Female; Follow-Up Studies; Genotype; Homocysteine; Homozygote; Humans; Hyperplasia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Risk; Stents; Tunica Intima; Ultrasonography, Interventional; Vascular Patency | 2001 |
Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering.
Topics: Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Hematinics; Homocysteine; Humans; Male; Middle Aged; Tetrahydrofolates; Time Factors; Treatment Outcome; Vasodilation | 2002 |
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
Topics: Coronary Artery Disease; Edible Grain; Female; Flour; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Middle Aged; Riboflavin; Vitamin B 6 | 2002 |
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.
Topics: Acute Disease; Aged; Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2002 |
Effect of treatment with folic acid and vitamin B6 on lipid and homocysteine concentrations in patients with coronary artery disease.
Topics: Aged; Coronary Artery Disease; Dietary Supplements; Female; Folic Acid; Genotype; Hematinics; Homocysteine; Humans; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prospective Studies; Treatment Outcome; Vitamin B 6 | 2002 |
314 other study(ies) available for homocysteine and Coronary Artery Disease
Article | Year |
---|---|
Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults ≤ 35 years of age: a hospital-based observational study.
Topics: Adolescent; Adult; Age of Onset; Beijing; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Smoking; Young Adult | 2021 |
High mobility group box 1 and homocysteine as preprocedural predictors for contrast-induced acute kidney injury after percutaneous coronary artery intervention.
Topics: Acute Kidney Injury; Arteries; Contrast Media; Coronary Artery Disease; Creatinine; HMGB1 Protein; Homocysteine; Humans; Percutaneous Coronary Intervention; Risk Factors | 2022 |
The expression of SAH, IL-1β, Hcy, TNF-α and BDNF in coronary heart disease and its relationship with the severity of coronary stenosis.
Topics: Brain-Derived Neurotrophic Factor; Coronary Artery Disease; Coronary Stenosis; Homocysteine; Humans; Interleukin-1beta; Retrospective Studies; Tumor Necrosis Factor-alpha | 2022 |
Relationship between Coronary VH-IVUS Plaque Characteristics and CTRP9, SAA, and Hcy in Patients with Coronary Heart Disease.
Topics: Atherosclerosis; Coronary Artery Disease; Homocysteine; Humans; Plaque, Atherosclerotic | 2022 |
Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease.
Topics: Angina, Unstable; Cholesterol, HDL; Coronary Artery Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homer Scaffolding Proteins; Homocysteine; Humans; Hypertension; Myocardial Infarction; Retrospective Studies | 2022 |
The role of methylenetetrahydrofolate reductase C677T gene polymorphism as a risk factor for coronary artery disease: a cross-sectional study in the Sidoarjo Regional General Hospital.
Topics: Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic | 2022 |
Gut Microbiota and Coronary Plaque Characteristics.
Topics: Biomarkers; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Fibrinogen; Gastrointestinal Microbiome; Homocysteine; Humans; Interleukin-6; Plaque, Atherosclerotic; RNA, Ribosomal, 16S; Tomography, Optical Coherence; Ultrasonography, Interventional | 2022 |
Role of plasma homocysteine levels and other associated factors with coronary artery disease among Palestinian patients in North Palestine: a case control study.
Topics: Arabs; Case-Control Studies; Coronary Artery Disease; Homocysteine; Humans; Hypertension; Male; Middle Aged | 2022 |
Biomarkers associated with coronary high-risk plaques.
Topics: Bile Acids and Salts; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Creatinine; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Plaque, Atherosclerotic; Predictive Value of Tests; Prothrombin; Tomography, Optical Coherence; Ultrasonography, Interventional | 2022 |
The relationship between hyperhomocysteinemia and total coronary artery occlusion: a cross-sectional study from Southwest China.
Topics: Adult; Aged; China; Coronary Artery Disease; Coronary Occlusion; Cross-Sectional Studies; Homocysteine; Humans; Hyperhomocysteinemia; Male; Overweight; Risk Factors | 2023 |
Use of serum folate and vitamin B
Topics: Coronary Artery Disease; Folic Acid; Homocysteine; Humans; Prospective Studies; Vitamin B 12; Vitamin B 12 Deficiency; Vitamins | 2023 |
Correlation analysis of lipid accumulation index, triglyceride-glucose index and H-type hypertension and coronary artery disease.
Topics: Cholesterol, HDL; Constriction, Pathologic; Coronary Artery Disease; Glucagon-Like Peptide 1; Glucose; Homocysteine; Humans; Hypertension | 2023 |
Association Between MTHFR Gene Common Variants, Serum Homocysteine, and Risk of Early-Onset Coronary Artery Disease: A Case-Control Study.
Topics: Adult; Case-Control Studies; China; Coronary Artery Disease; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors | 2020 |
Homocysteine is an independent predictor of long-term cardiac mortality in patients with stable coronary artery disease in the era of statins.
Topics: Acute Coronary Syndrome; Aged; Arrhythmias, Cardiac; Cardiovascular Diseases; Cholesterol, LDL; Coronary Artery Disease; Coronary Stenosis; Female; Greece; Homocysteine; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Ischemic Stroke; Male; Middle Aged; Myocardial Revascularization; Prognosis; Proportional Hazards Models; Registries | 2020 |
Effect of High Homocysteine Level on the Severity of Coronary Heart Disease and Prognosis After Stent Implantation.
Topics: Aged; Aged, 80 and over; Biomarkers; Coronary Artery Disease; Drug-Eluting Stents; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2020 |
Cysteine is a better predictor of coronary artery disease than conventional homocysteine in high-risk subjects under preventive medication.
Topics: Adult; Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Cysteine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Portugal; Predictive Value of Tests; Prevalence; Primary Prevention; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Secondary Prevention; Severity of Illness Index | 2020 |
Association of the methylene-tetrahydrofolate reductase gene rs1801133 C677T variant with serum homocysteine levels, and the severity of coronary artery disease.
Topics: Adult; Aged; Case-Control Studies; Coronary Artery Disease; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; ROC Curve; Severity of Illness Index; Tunisia; Young Adult | 2020 |
Plasma Homocysteine in Patients with Coronary and Carotid Artery Disease: A Case Control Study.
Topics: Adult; Aged; Angiography; Atherosclerosis; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Coronary Artery Disease; Disease Progression; Endothelium, Vascular; Female; Homocysteine; Humans; Inflammation; Male; Middle Aged; Risk Assessment; Risk Factors | 2020 |
Homocysteine concentration and adenosine A
Topics: Aged; Cells, Cultured; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Leukocytes, Mononuclear; Male; Receptor, Adenosine A2A | 2020 |
The impact of homocysteine on the risk of coronary artery diseases in individuals with diabetes: a Mendelian randomization study.
Topics: Case-Control Studies; Causality; Coronary Artery Disease; Diabetes Mellitus; Diabetic Angiopathies; Genetic Predisposition to Disease; Genome-Wide Association Study; Homocysteine; Humans; Linkage Disequilibrium; Mendelian Randomization Analysis; Meta-Analysis as Topic; Metabolic Networks and Pathways; Odds Ratio; Polymorphism, Single Nucleotide | 2021 |
Cut-off value of serum homocysteine in relation to increase of coronary artery calcification.
Topics: Coronary Artery Disease; Coronary Vessels; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; ROC Curve; Vascular Calcification | 2021 |
Higher serum level of Cystatin C: An additional risk factor of CAD.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cholesterol; Coronary Artery Disease; Cystatin C; Female; Glomerular Filtration Rate; Heart Disease Risk Factors; Homocysteine; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Logistic Models; Male; Middle Aged; Risk Assessment; Triglycerides; Uric Acid | 2021 |
Association between vitamin D deficiency and serum Homocysteine levels and its relationship with coronary artery disease.
Topics: Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin D; Vitamin D Deficiency | 2021 |
Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reactivity in patients on dual antiplatelet therapy.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Platelets; Coronary Artery Disease; Dual Anti-Platelet Therapy; Female; Homocysteine; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Time Factors; Treatment Outcome; Up-Regulation | 2021 |
Analysis of the association and predictive value of hyperhomocysteinaemia for obstructive coronary artery disease.
Topics: China; Coronary Angiography; Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; Retrospective Studies; Risk Factors | 2021 |
Interleukin-1beta may act on hepatocytes to boost plasma homocysteine - The increased cardiovascular risk associated with elevated homocysteine may be mediated by this cytokine.
Topics: Animals; Coronary Artery Disease; Evidence-Based Medicine; Homocysteine; Humans; Immunologic Factors; Inflammation Mediators; Interleukin-1beta; Models, Cardiovascular; Models, Immunological; Peptide Fragments | 2017 |
Aldosterone modulates blood homocysteine and cholesterol in coronary artery disease patients - a possible impact on atherothrombosis?
Topics: Adrenal Glands; Aged; Aldosterone; Animals; Arachidonic Acid; Cholesterol; Collagen; Coronary Artery Disease; Creatinine; Female; Homocysteine; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Thrombosis | 2018 |
Genome-wide association study of homocysteine in African Americans from the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Coronary Artery Risk in Young Adults study.
Topics: Adult; Alleles; Atherosclerosis; Black or African American; Coronary Artery Disease; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Homocysteine; Humans; Longitudinal Studies; Male; Middle Aged; Mississippi; Polymorphism, Single Nucleotide; Population Surveillance; Quantitative Trait Loci; Quantitative Trait, Heritable; Young Adult | 2018 |
The anti-inflammatory effect of microRNA-383-3p interacting with IL1R2 against homocysteine-induced endothelial injury in rat coronary arteries.
Topics: Animals; Apoptosis; Coronary Artery Disease; Coronary Vessels; Cytokines; Endothelium, Vascular; Homocysteine; Inflammation; Male; MicroRNAs; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-1 Type II | 2018 |
Gender differences in homocysteine concentrations, a population-based cross-sectional study.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; Coronary Artery Disease; Cross-Sectional Studies; Female; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Israel; Male; Middle Aged; Prevalence; Prognosis; Risk Factors; Sex Factors; Vitamin B 12 Deficiency; Young Adult | 2019 |
Coefficients in the CAVI Equation and the Comparison Between CAVI With and Without the Coefficients Using Clinical Data.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Peripheral Arterial Disease; Prognosis; Prospective Studies; Risk Factors; Survival Rate | 2019 |
Determination of Serum Homocysteine and Hypersensitive C-reactive Protein and Their Correlation with Premature Coronary Heart Disease.
Topics: Age Factors; Aged; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Severity of Illness Index | 2019 |
Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China.
Topics: Biomarkers; China; Comorbidity; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Reproducibility of Results; Risk Factors; Sensitivity and Specificity | 2013 |
Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Artery Disease; Dyslipidemias; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; India; Male; Middle Aged; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2013 |
[Occurrence and prognosis of coronary slow flow in emergency percutaneous coronary intervention: correlations with homocysteine].
Topics: Adult; Aged; Coronary Artery Disease; Emergency Treatment; Female; Homocysteine; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prognosis; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2013 |
Simultaneous determination of homocysteine and asymmetric dimethylarginine in human urine by liquid chromatography-tandem mass spectrometry.
Topics: Arginine; Biomarkers; Chromatography, Liquid; Coronary Artery Disease; Homocysteine; Humans; Limit of Detection; Linear Models; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2013 |
Predictive value of plasma asymmetric dimethylarginine, homocysteine, and high-sensitive CRP levels in occult coronary artery disease: A multidetector-row computed tomography study.
Topics: Arginine; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Multidetector Computed Tomography; Prognosis; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity | 2015 |
Higher homocysteine levels in young Indian adults: impact of vitamin B12 & folate deficiencies.
Topics: Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2) | 2013 |
Plasma homocysteine and coronary artery calcification in Korean men.
Topics: Adult; Age Factors; Asian People; Biomarkers; Coronary Angiography; Coronary Artery Disease; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prevalence; Republic of Korea; Retrospective Studies; Risk Factors; Sex Factors; Vascular Calcification | 2015 |
An MTHFR variant, plasma homocysteine levels and late-onset coronary artery disease in subjects from southern Iran.
Topics: Age of Onset; Aged; Biomarkers; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Female; Gene Frequency; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Iran; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Phenotype; Polymorphism, Single Nucleotide; Retrospective Studies; Risk Factors | 2013 |
Authors' response.
Topics: Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2) | 2013 |
Association of plasma leptin, homocysteine and nitric oxide levels with the presence and unstability of coronary artery disease.
Topics: Aged; Angina, Stable; Angina, Unstable; Chromatography, High Pressure Liquid; Coronary Artery Disease; Female; Homocysteine; Humans; Immunoenzyme Techniques; Leptin; Male; Middle Aged; Nitric Oxide; Odds Ratio; Risk Factors; ROC Curve; Spectrometry, Fluorescence | 2014 |
Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Chi-Square Distribution; Contrast Media; Coronary Angiography; Coronary Artery Disease; Creatinine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Kidney; Logistic Models; Male; Odds Ratio; Percutaneous Coronary Intervention; Registries; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Up-Regulation | 2015 |
Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study.
Topics: Aged; Aged, 80 and over; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Prospective Studies | 2014 |
The relationship between microalbuminuria and isolated coronary artery ectasia.
Topics: Albuminuria; Case-Control Studies; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Creatinine; Dilatation, Pathologic; Female; Homocysteine; Humans; Male; Middle Aged | 2014 |
A modified portfolio diet complements medical management to reduce cardiovascular risk factors in diabetic patients with coronary artery disease.
Topics: Aged; Biomarkers; Blood Glucose; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Dietary Fats; Dietary Fiber; Energy Intake; Female; Homocysteine; Humans; Male; Middle Aged; Motor Activity; Patient Compliance; Pilot Projects; Risk Factors; Soybean Proteins | 2015 |
Association of serum homocysteine levels with the severity and calcification of coronary atherosclerotic plaques detected by coronary CT angiography.
Topics: Adult; Aged; Biomarkers; Cerebral Angiography; Chi-Square Distribution; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Cross-Sectional Studies; Female; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Multidetector Computed Tomography; Odds Ratio; Plaque, Atherosclerotic; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Vascular Calcification | 2014 |
High-sensitivity C-reactive Protein, Lipoprotein(a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Female; Follow-Up Studies; Homocysteine; Humans; Japan; Lipoprotein(a); Male; Middle Aged; Peripheral Arterial Disease; Prognosis; Risk Factors | 2015 |
Association of obstructive sleep apnea with homocystein, nitric oxide and total antioxidant capacity levels in patients with or without coronary artery disease.
Topics: Antioxidants; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide; Polysomnography; Sleep Apnea, Obstructive | 2014 |
Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid.
Topics: Aged; Aged, 80 and over; Aspirin; Biomarkers; Blood Platelets; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Treatment Outcome | 2015 |
Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Creatine Kinase, MB Form; Female; Fibrinogen; Homocysteine; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Neopterin; Troponin | 2015 |
[A prospective study on the association of plasma homocysteine level with stroke in hypertensive patients].
Topics: Antihypertensive Agents; Coronary Artery Disease; Coronary Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hypertension; Incidence; Male; Prospective Studies; Socioeconomic Factors; Stroke | 2015 |
Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Cholesterol, HDL; Coronary Artery Disease; Drug Administration Schedule; Female; Homocysteine; Humans; Hyperhomocysteinemia; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prospective Studies; Pyrimidines; Retrospective Studies; Triglycerides | 2016 |
Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease.
Topics: Adenosine; Aged; Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Tumor Cells, Cultured; Uric Acid | 2016 |
[Relationship between hyperhomocysteine and long-term outcome of coronary artery disease patients after drug-eluting stent implantation].
Topics: Coronary Artery Disease; Drug-Eluting Stents; Homocysteine; Humans; Prospective Studies; Time Factors; Treatment Outcome | 2015 |
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study.
Topics: Age Factors; Aged; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Diabetic Angiopathies; Diabetic Cardiomyopathies; Diabetic Nephropathies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Hypertriglyceridemia; Italy; Male; Middle Aged; Prevalence; Renal Insufficiency; Risk Factors; Severity of Illness Index; Smoking | 2016 |
Correlation between the 677C>T polymorphism in the methylene tetrahydrofolate reductase gene and serum homocysteine levels in coronary heart disease.
Topics: Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic | 2016 |
Increased homocysteine and lipoprotein(a) levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Ankle Brachial Index; Atherosclerosis; Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Chi-Square Distribution; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Italy; Lipoprotein(a); Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Predictive Value of Tests; Prognosis; Pulse Wave Analysis; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Ultrasonography, Doppler; Up-Regulation | 2016 |
[HOMOCYSTEINE AS A PROGNOSTIC MARKER OF ATRIAL REMODELING AND CLINICAL PICTURE IN PATIENTS WITH PAROXYSMAL AND PERSISTENT FORMS OF ATRIAL FIBRILLATION].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Remodeling; Biomarkers; Coronary Artery Disease; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Statistics as Topic | 2016 |
Statins, renal function and homocysteine.
Topics: Coronary Artery Disease; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Lipid Peroxidation; Renal Insufficiency, Chronic | 2016 |
Prognostic impact of homocysteine levels and homocysteine thiolactonase activity on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Carboxylic Ester Hydrolases; Coronary Artery Disease; Female; Homocysteine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Registries; Regression Analysis; ROC Curve | 2017 |
Homocysteine concentration in coronary artery disease: Influence of three common single nucleotide polymorphisms.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Area Under Curve; Biomarkers; Case-Control Studies; Chi-Square Distribution; Coronary Artery Disease; Cystathionine beta-Synthase; Disease Progression; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Heterozygote; Homocysteine; Homozygote; Humans; Kaplan-Meier Estimate; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Phenotype; Polymorphism, Single Nucleotide; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Risk Factors; ROC Curve; Stroke; Time Factors | 2017 |
Diagnostic value of joint detection of homocysteine and RDW CV on acute myocardial infarction. Retracted.
Topics: Aged; Coronary Artery Disease; Erythrocyte Indices; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Sensitivity and Specificity | 2016 |
Associations between homocysteine metabolism related SNPs and carotid intima-media thickness: a Chinese sib pair study.
Topics: Asian People; Atherosclerosis; Carotid Artery, Common; Carotid Intima-Media Thickness; Coronary Artery Disease; Epistasis, Genetic; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Polymorphism, Single Nucleotide; Siblings | 2017 |
Homocysteine-reducing B vitamins and ischemic heart disease: a separate-sample Mendelian randomization analysis.
Topics: Adult; Aged; Case-Control Studies; Coronary Artery Disease; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Mendelian Randomization Analysis; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Vitamin B 12; Vitamin B Complex | 2017 |
Serum Klotho (but not haplotypes) associate with the post-myocardial infarction status of older adults.
Topics: Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Anthropometry; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Cross-Sectional Studies; Energy Intake; Enzyme-Linked Immunosorbent Assay; Female; Genotyping Techniques; Glucuronidase; Haplotypes; Homocysteine; Humans; Klotho Proteins; Male; Middle Aged; Myocardial Infarction; Nutrition Assessment; Reference Values; Risk Factors; Sex Factors; Statistics, Nonparametric; Stroke | 2016 |
Serum high concentrations of homocysteine and low levels of folic acid and vitamin B
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; China; Coronary Artery Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Incidence; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Severity of Illness Index; Vitamin B 12 | 2017 |
Association of hyperhomocysteinemia and Chlamydia pneumoniae infection with carotid atherosclerosis and coronary artery disease in Japanese patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Bacterial; Carotid Artery Diseases; Case-Control Studies; Chlamydia Infections; Chlamydophila pneumoniae; Coronary Artery Disease; Cross-Sectional Studies; Female; Health Surveys; Homocysteine; Humans; Hyperhomocysteinemia; Immunoglobulin G; Japan; Male; Middle Aged | 2008 |
High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
Topics: Alleles; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Is homocysteine a mediator of atrial dysfunction or just another marker of endothelial dysfunction?
Topics: Atrial Fibrillation; Biomarkers; Coronary Artery Disease; Endothelium, Vascular; Homocysteine; Humans; Ventricular Dysfunction, Left | 2008 |
Detection of altered global DNA methylation in coronary artery disease patients.
Topics: Adult; Aged; Aging; Apolipoproteins E; Case-Control Studies; Chromosome Mapping; Cohort Studies; Coronary Artery Disease; Diet; DNA Methylation; Genome, Human; Homocysteine; Humans; Middle Aged | 2008 |
Cardiovascular disease--the silent killer in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Comorbidity; Coronary Artery Disease; Endothelium, Vascular; Homocysteine; Humans; Leptin | 2008 |
Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Asian; Black or African American; Coronary Artery Disease; Cystathionine beta-Synthase; Enzymes; Female; Ferredoxin-NADP Reductase; Folic Acid; Genotype; Hispanic or Latino; Homocysteine; Humans; Lupus Erythematosus, Systemic; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; White People | 2008 |
[C-reactive protein and homocysteine as risk factors of atherosclerosis].
Topics: Adult; Biomarkers; C-Reactive Protein; Cholesterol; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 2008 |
Lowering homocysteine with B vitamins in patients with coronary artery disease.
Topics: Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex | 2008 |
Lowering homocysteine with B vitamins in patients with coronary artery disease.
Topics: Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex | 2008 |
Lowering homocysteine with B vitamins in patients with coronary artery disease.
Topics: Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex | 2008 |
[A comparison of influence of homocysteine on peroxidase metabolism between elderly patients with or without coronary artery disease].
Topics: Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Lipids; Male; Malondialdehyde; Peroxidases; Superoxide Dismutase | 2008 |
Polymorphisms of the methylenetetrahydrofolate reductase, vascular endothelial growth factor, endothelial nitric oxide synthase, monocyte chemoattractant protein-1 and apolipoprotein E genes are not associated with carotid intima-media thickness.
Topics: Apolipoproteins E; C-Reactive Protein; Carotid Artery, Common; Chemokine CCL2; Coronary Artery Disease; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Nitric Oxide Synthase Type III; Polymorphism, Single Nucleotide; Tunica Intima; Tunica Media; Vascular Endothelial Growth Factor A | 2009 |
Effects of metoprolol and diltiazem on plasma homocysteine levels in patients with isolated coronary artery ectasia.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Artery Disease; Dilatation, Pathologic; Diltiazem; Female; Folic Acid; Homocysteine; Humans; Male; Metoprolol; Middle Aged; Treatment Outcome; Vitamin B 12 | 2009 |
Association of genetic variants in Methylenetetrahydrofolate Reductase and Paraoxonase-1 genes with homocysteine, folate and vitamin B12 in coronary artery disease.
Topics: Aged; Aryldialkylphosphatase; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Vitamin B 12 | 2009 |
Homocysteine-lowering B vitamins do not lower mortality or cardiovascular events.
Topics: Aged; Aortic Valve Stenosis; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk; Survival Analysis; Survival Rate; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
Topics: Aged; Aryldialkylphosphatase; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Homocysteine; Humans; Lipoproteins, LDL; Male; Middle Aged; Polymorphism, Genetic | 2009 |
Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Case-Control Studies; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Methylmalonic Acid; Middle Aged; Polymorphism, Genetic; Risk Factors | 2010 |
Siglec-1 on monocytes is a potential risk marker for monitoring disease severity in coronary artery disease.
Topics: Biomarkers; C-Reactive Protein; Coronary Artery Disease; Electrophoresis, Agar Gel; Flow Cytometry; Gene Expression Regulation; Homocysteine; Humans; Membrane Glycoproteins; Monocytes; Receptors, Immunologic; Risk Factors; RNA; RNA, Messenger; Sialic Acid Binding Ig-like Lectin 1 | 2009 |
High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia.
Topics: Analysis of Variance; Animals; Apoptosis; CCAAT-Binding Factor; Coronary Artery Disease; Diet, Atherogenic; Dietary Supplements; Disease Models, Animal; Endothelium, Vascular; Homocysteine; Hyperlipidemias; Male; Methionine; Nitric Oxide; Oxidative Stress; Probability; Rabbits; Random Allocation; Reference Values; Sensitivity and Specificity; Taurine | 2009 |
MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis.
Topics: Aged; Coronary Artery Disease; Endothelium, Vascular; Female; Genotype; Homocysteine; Humans; Male; Mammary Arteries; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Nitric Oxide; Oxidation-Reduction; Phenols; Plant Extracts; Polymorphism, Genetic; Saphenous Vein; Superoxides; Tetrahydrofolates | 2009 |
Plasma leptin in insulin-resistant and insulin-nonresistant coronary artery disease and its association with cardio-metabolic risk factors among Asian Indians.
Topics: Adult; Asian People; Body Mass Index; Coronary Artery Disease; Female; Fibrinogen; Glucose; Homocysteine; Humans; India; Insulin; Insulin Resistance; Leptin; Lipids; Male; Middle Aged; Risk Factors; Waist Circumference | 2009 |
Association between asymmetric dimethylarginine and neopterin in patients with and without angiographic coronary artery disease.
Topics: Arginine; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Folic Acid; Homocysteine; Humans; Middle Aged; Neopterin; Risk Factors; Vitamin B 12; Vitamin B 6 | 2009 |
Homocysteine and MTHFR and VEGF gene polymorphisms: impact on coronary artery disease.
Topics: Coronary Artery Disease; Epidemiologic Methods; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Vascular Endothelial Growth Factor A | 2009 |
Clinical relevance of plasma homocysteine levels in Taiwanese patients with coronary artery disease.
Topics: Acute Coronary Syndrome; Aged; Chromatography, High Pressure Liquid; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Taiwan | 2008 |
C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients.
Topics: Adult; C-Reactive Protein; CD40 Ligand; Cohort Studies; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 2009 |
Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease.
Topics: Adult; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Survival Analysis; Treatment Outcome; Vitamin B Complex | 2009 |
Effect of renal transplantation on coronary artery calcification in hemodialysis patients.
Topics: Adult; Calcinosis; Cholesterol; Coronary Artery Disease; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis; Triglycerides; Ultrasonography; Young Adult | 2009 |
Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Coronary Artery Bypass; Coronary Artery Disease; Factor XIII; Female; Fibrin; Fibrinolysis; Homocysteine; Humans; Male; Middle Aged; Permeability; Polymorphism, Genetic; Risk Assessment | 2009 |
Metabolic syndrome and homocysteine level as predictors of the severity of coronary artery disease in patients with carotid stenosis.
Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Coronary Angiography; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metabolic Syndrome; Middle Aged; Risk Factors | 2009 |
Trait anger, hostility, serum homocysteine, and recurrent cardiac events after percutaneous coronary interventions.
Topics: Aged; Anger; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Hostility; Humans; Lipids; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors | 2009 |
Hyperhomocysteinemia-induced myocardial injury after coronary artery bypass.
Topics: Aged; Biomarkers; Constriction; Coronary Artery Bypass; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Linear Models; Male; Middle Aged; Myocardial Reperfusion Injury; Myocardium; Odds Ratio; Prospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Troponin T; Up-Regulation | 2009 |
Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers.
Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Creatinine; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Neopterin; Vitamin B 12 | 2010 |
Determinants of white matter hyperintensity volume in patients with acute ischemic stroke.
Topics: Adult; Aged; Aging; Biomarkers; Brain; Brain Ischemia; Cohort Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Hypertension; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Retrospective Studies; Risk Factors; Stroke | 2010 |
Reduced kidney function estimated by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease: association with homocysteine and other cardiovascular risk factors.
Topics: Aged; Cardiovascular Diseases; Coronary Artery Disease; Cystatin C; Female; Homocysteine; Humans; Hypertension; Kidney; Male; Middle Aged; Risk Factors; Treatment Outcome | 2010 |
Association of the C677T MTHFR polymorphism with homocysteine, ox-LDL levels, and thiolactonase activities in the severity of coronary syndrome.
Topics: Aged; C-Reactive Protein; Carboxylic Ester Hydrolases; Cohort Studies; Coronary Artery Disease; Female; Genotype; Homocysteine; Humans; Lipoproteins, LDL; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors | 2010 |
Decreased serum levels of thioredoxin in patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity.
Topics: Aged; Analysis of Variance; Biomarkers; Blood Glucose; Case-Control Studies; China; Coronary Angiography; Coronary Artery Disease; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Lipids; Male; Middle Aged; Severity of Illness Index; Thioredoxin-Disulfide Reductase; Thioredoxins | 2010 |
Association of C-reactive protein and homocysteine with subclinical coronary plaque subtype and stenosis using low-dose MDCT coronary angiography.
Topics: Adult; Aged; C-Reactive Protein; Constriction, Pathologic; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Risk; Risk Factors | 2010 |
Relationship between L-arginine/asymmetric dimethylarginine, homocysteine, folic acid, vitamin B levels, and coronary artery ectasia.
Topics: Aged; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Dilatation, Pathologic; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Turkey; Vitamin B Complex | 2010 |
The plasma homocysteine concentrations and prior myocardial infarction.
Topics: Aged; Biomarkers; Body Mass Index; Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors | 2010 |
[Smoking enhances the decrease of adiponectin level in patients with coronary artery disease, carriers of MTHFR 677T and PON1 55M alleles].
Topics: Adiponectin; Adult; Aged; Angina Pectoris; Aryldialkylphosphatase; Causality; Comorbidity; Coronary Angiography; Coronary Artery Disease; Female; Heterozygote; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Smoking | 2010 |
Homocysteine, fibrinogen and lipid profile in children of young adults with coronary artery disease.
Topics: Adolescent; Adult; Blood Chemical Analysis; Child; Child, Preschool; Coronary Artery Disease; Fibrinogen; Homocysteine; Humans; India; Lipids; Middle Aged; Parents; Risk Factors | 2011 |
Are stroke biomarkers seeing brain vessels in patients with ischemic stroke?: a C-reactive protein and homocysteine study.
Topics: Aged; Biomarkers; Brain; C-Reactive Protein; Cerebral Arteries; Coronary Artery Disease; Coronary Vessels; Female; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Stroke | 2011 |
Matrix metalloproteinase-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Chromatography, High Pressure Liquid; Coronary Artery Disease; DNA Primers; Female; Gene Frequency; Genetic Association Studies; Homocysteine; Humans; Iran; Lipids; Lipoproteins; Male; Matrix Metalloproteinase 9; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Promoter Regions, Genetic | 2012 |
Tetra primer ARMS-PCR relates folate/homocysteine pathway genes and ACE gene polymorphism with coronary artery disease.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aryldialkylphosphatase; Case-Control Studies; Coronary Artery Disease; Cystathionine beta-Synthase; Epistasis, Genetic; Female; Folic Acid; Gene Frequency; Genetic Association Studies; Genotype; Homocysteine; Humans; INDEL Mutation; Logistic Models; Male; Metabolic Networks and Pathways; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2011 |
Serum total homocysteine and lipoprotein (a) levels in acute myocardial infarction and their response to treatment with vitamins.
Topics: Biomarkers; Coronary Artery Disease; Female; Homocysteine; Humans; Lipoprotein(a); Myocardial Infarction; Vitamin B Complex | 2011 |
Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.
Topics: Aged; Biomarkers; Comorbidity; Coronary Artery Disease; Female; Homocysteine; Humans; Hungary; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prevalence; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Sex Distribution; Statistics as Topic | 2012 |
Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects.
Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein A-I; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Cysteine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lipids; Male; Middle Aged; Prevalence; Risk Factors; Statistics, Nonparametric | 2011 |
Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification.
Topics: Adult; Biomarkers; Blood Sedimentation; C-Reactive Protein; Calcinosis; Case-Control Studies; Comorbidity; Coronary Artery Disease; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Homocysteine; Humans; Insulin Resistance; Kidney; Logistic Models; Lupus Erythematosus, Systemic; Middle Aged; Resistin; Risk Factors | 2011 |
Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc.
Topics: Cell Adhesion; Coronary Artery Disease; CpG Islands; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Endothelium, Vascular; Enzyme Inhibitors; Epigenesis, Genetic; HCT116 Cells; HEK293 Cells; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Monocytes; Nitric Oxide; Oxidative Stress; Promoter Regions, Genetic; Reactive Oxygen Species; RNA Interference; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Time Factors; Transcription, Genetic; Transfection; U937 Cells; Up-Regulation | 2011 |
Altered fibrin clot properties in patients with retinal vein occlusion.
Topics: C-Reactive Protein; Coronary Artery Disease; Female; Fenofibrate; Fibrin; Fibrinolysis; Heptanoic Acids; Homocysteine; Humans; Hypersensitivity, Immediate; Laser Coagulation; Lipoprotein(a); Male; Pyrroles; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Tetrahydroisoquinolines; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2011 |
Predictors of residual cardiovascular risk in patients on statin therapy for primary prevention.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cholesterol, LDL; Coronary Artery Disease; Elasticity; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Primary Prevention; Risk Factors; Vascular Calcification; Vascular Stiffness; Waist Circumference | 2011 |
Value and level of plasma homocysteine in patients with angina pectoris undergoing coronary angiographic study.
Topics: Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Coronary Occlusion; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Analysis | 2011 |
A two-step genetic study on quantitative precursors of coronary artery disease in a homogeneous Indian population: case-control association discovery and validation by transmission-disequilibrium test.
Topics: Adult; Apolipoproteins B; Biomarkers; Case-Control Studies; Cholesterol; Coronary Artery Disease; Female; Fibrinogen; Genetic Association Studies; Homocysteine; Humans; India; Linkage Disequilibrium; Male; Middle Aged; NF-kappa B; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Vascular Endothelial Growth Factor A | 2011 |
Effect of oral contraceptive therapy on homocysteine and C-reactive protein levels in women: an observational study.
Topics: Adult; C-Reactive Protein; Case-Control Studies; Contraceptives, Oral, Combined; Coronary Artery Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Young Adult | 2011 |
Homocysteine is related to aortic mineralization in patients with ischemic heart disease.
Topics: Calcinosis; Coronary Artery Disease; Cross-Sectional Studies; Female; Heart Valve Diseases; Homocysteine; Humans; Male; Mammary Arteries; Middle Aged; Myocardial Ischemia; Prognosis | 2012 |
Endothelial progenitor cells are associated with plasma homocysteine in coronary artery disease.
Topics: Adult; Aged; Coronary Artery Disease; Endothelium, Vascular; Female; Flow Cytometry; Homocysteine; Humans; Male; Middle Aged; Stem Cells | 2011 |
MTHFR C677T polymorphism, homocysteine and B-vitamins status in a sample of Chinese and Malay subjects in Universiti Putra Malaysia.
Topics: Adult; Asian People; Coronary Artery Disease; Cross-Sectional Studies; DNA; DNA Primers; Female; Homocysteine; Humans; Malaysia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymerase Chain Reaction; Polymorphism, Genetic; Students; Vitamin B 12; Young Adult | 2011 |
Association factors of target organ damage: analysis of 17,682 elderly hypertensive patients in China.
Topics: Aged; Aged, 80 and over; Aortic Diseases; Cerebrovascular Disorders; China; Cholesterol, LDL; Coronary Artery Disease; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies | 2011 |
Genetic and environmental influences on total plasma homocysteine and its role in coronary artery disease risk.
Topics: Adult; Aged; Constriction, Pathologic; Coronary Artery Disease; Diuretics; Female; Gene-Environment Interaction; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Lebanon; Liver-Specific Organic Anion Transporter 1; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Organic Anion Transporters; Polymorphism, Genetic; Risk Factors | 2012 |
Combination of high-sensitivity C-reactive protein and homocysteine may predict an increased risk of coronary artery disease in Korean population.
Topics: Adult; Aged; Asian People; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Surveys and Questionnaires; Young Adult | 2012 |
Evaluation of possible subclinical atherosclerosis in adolescents with a family history of premature atherosclerosis.
Topics: Adolescent; Adult; Age of Onset; Aorta; Asymptomatic Diseases; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Intima-Media Thickness; Case-Control Studies; Coronary Artery Disease; Echocardiography, Doppler, Pulsed; Elasticity; Fathers; Female; Genetic Predisposition to Disease; Heredity; Homocysteine; Humans; Male; Pedigree; Phenotype; Pulsatile Flow; Risk Assessment; Risk Factors; Turkey | 2012 |
Association between endothelial nitric oxide gene intron 4a4b VNTR polymorphism and plasma homocysteine concentrations in Tunisian male patients with myocardial infarction.
Topics: Adult; Alleles; Coronary Artery Disease; Endothelium, Vascular; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Introns; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase Type III; Polymerase Chain Reaction; Polymorphism, Genetic; Tunisia | 2012 |
Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians.
Topics: Adult; Cholesterol; Coronary Artery Disease; Female; Folic Acid; Genetic Association Studies; Homocysteine; Humans; Hyperhomocysteinemia; India; Lipoproteins, HDL; Lipoproteins, LDL; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors; Smoking; Triglycerides; Vitamin B 12 | 2012 |
Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?
Topics: Adult; Aged; Arginine; Atherosclerosis; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Risk Factors | 2012 |
Association between plasma homocysteine and myocardial SPECT abnormalities in patients referred for suspected myocardial ischaemia.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; Cardiotonic Agents; Chi-Square Distribution; Coronary Artery Disease; Exercise Test; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Myocardial Perfusion Imaging; Odds Ratio; Predictive Value of Tests; Prospective Studies; Referral and Consultation; Risk Assessment; Risk Factors; Severity of Illness Index; South Africa; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Up-Regulation; Vasodilator Agents; Ventricular Function, Left | 2012 |
Oxidative stress in coronary artery disease: epigenetic perspective.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Cell Line; Coronary Artery Disease; Decitabine; DNA Methylation; Endothelial Cells; Epigenesis, Genetic; Female; Ferredoxin-NADP Reductase; Folic Acid; Glutathione S-Transferase pi; Glycine Hydroxymethyltransferase; Homocysteine; Humans; Hydroxamic Acids; Male; Malondialdehyde; Membrane Proteins; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidative Stress; Promoter Regions, Genetic; Protein Carbonylation; Proto-Oncogene Proteins; Superoxide Dismutase; Young Adult | 2013 |
Cardiovascular risk factors in Chilean patients with rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Chile; Cohort Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Risk Factors | 2002 |
Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chromosome Segregation; Coronary Angiography; Coronary Artery Disease; Family; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Pedigree; Vitamin B 12 | 2002 |
Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery disease.
Topics: Aged; Biomarkers; Blood Pressure; C-Reactive Protein; Coronary Artery Disease; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Regression Analysis; Severity of Illness Index; Treatment Outcome | 2002 |
Homocysteine and other vascular risk factors in patients with phenylketonuria on a diet.
Topics: Child; Child, Preschool; Coronary Artery Disease; Diet, Protein-Restricted; Endothelin-1; Folic Acid; Homocysteine; Humans; Lipids; Nutrition Assessment; Phenylalanine; Phenylketonurias; Risk Factors; Vitamin B 12; Vitamin B 6 | 2002 |
The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study.
Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease Progression; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Assessment; ROC Curve | 2002 |
Helicobacter pylori infection does not affect the serum level of homocysteine.
Topics: Adult; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Artery Disease; Female; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Sex Factors | 2002 |
Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques.
Topics: Adult; Analysis of Variance; Coronary Artery Disease; Coronary Thrombosis; Death, Sudden, Cardiac; Diabetes Mellitus; Fibrosis; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Risk Factors | 2002 |
Elevated homocysteine serum level is associated with low enrichment of homocysteine in coronary arteries of patients with coronary artery disease.
Topics: Case-Control Studies; Coronary Artery Disease; Coronary Vessels; Female; Heart Transplantation; Homocysteine; Humans; Immunohistochemistry; Interleukin-6; Male; Middle Aged; Muscle, Smooth, Vascular | 2002 |
Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Parkinson Disease; Risk Factors; Vitamin B 12 | 2003 |
Homocysteine--are we making a mountain out of a molehill?
Topics: Biomarkers; Coronary Artery Disease; Homocysteine; Humans; India; Male; Prognosis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index | 2002 |
Plasma homocysteine concentration and coronary artery disease in Asian Indians.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Homocysteine; Humans; Incidence; India; Male; Middle Aged; Probability; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index | 2002 |
Body iron stores and coronary atherosclerosis assessed by coronary angiography.
Topics: Age Factors; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Ferritins; Fibrinogen; Homocysteine; Humans; Iron; Male; Middle Aged; Risk Factors; Severity of Illness Index; Sex Factors; Transferrin | 2002 |
The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects.
Topics: Adult; Aged; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Homocysteine; Humans; Linear Models; Male; Metabolic Syndrome; Middle Aged; Nitrites; Odds Ratio; Risk Factors; Triglycerides; Turkey | 2003 |
[Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors | 2002 |
Serum homocysteine concentrations and their relation to serum folate and vitamin B12 concentrations and coronary artery disease prevalence in an urban, bi-ethnic community.
Topics: Aged; Coronary Artery Disease; Female; Folic Acid; Hispanic or Latino; Homocysteine; Humans; Male; New Mexico; Prospective Studies; Risk Factors; Urban Health; Vitamin B 12; White People | 2003 |
Editorial comment: plasma homocysteine, coronary risk factors and serum nitrite in coronary artery disease and vascular syndrome X.
Topics: Coronary Artery Disease; Homocysteine; Humans; Metabolic Syndrome; Nitrites; Radiography; Risk Factors | 2003 |
The effects of hyperhomocysteinemia on the presence, extent, and severity of coronary artery disease.
Topics: Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Severity of Illness Index | 2003 |
Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery disease.
Topics: Analysis of Variance; Coronary Artery Disease; Cystathionine beta-Synthase; Gene Frequency; Genetic Variation; Genotype; Heterozygote; Homocysteine; Humans; Logistic Models; Methionine; Mutation; Polymorphism, Genetic; Risk Factors | 2003 |
[Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Blood Coagulation Factors; Case-Control Studies; Child; Child, Preschool; Coronary Artery Disease; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hypertension; Lipoprotein(a); Male; Obesity; Plasminogen Activator Inhibitor 1; Poland; Risk Factors; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2003 |
Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patients.
Topics: Age Distribution; Aged; Aged, 80 and over; Cerebrovascular Disorders; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Odds Ratio; Peripheral Vascular Diseases; Prevalence; Risk Factors | 2003 |
Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage.
Topics: Adult; Analysis of Variance; Coronary Artery Disease; DNA Damage; DNA Primers; Female; Ferredoxin-NADP Reductase; Heredodegenerative Disorders, Nervous System; Homocysteine; Humans; Italy; Lymphocytes; Male; Methylenetetrahydrofolate Reductase (NADPH2); Models, Biological; Polymorphism, Genetic | 2003 |
Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction.
Topics: Aged; Cardiac Catheterization; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Recurrence; Risk Factors; ROC Curve | 2003 |
A common mutation in 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in two Arab communities.
Topics: Adult; Arabs; Bahrain; Coronary Artery Disease; Female; Genetic Variation; Genetics, Population; Genotype; Homocysteine; Humans; Lebanon; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Venous Thrombosis | 2003 |
Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations.
Topics: Biomarkers; Cardiomyopathies; Coronary Artery Disease; Creatinine; Female; Florida; Folic Acid; Heart Failure; Heart Transplantation; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Oxygen Consumption; Pulmonary Wedge Pressure; Retrospective Studies; Severity of Illness Index; Statistics as Topic; Stroke Volume; Treatment Outcome | 2003 |
The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Topics: Adult; Aged; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Cysteine; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Threonine; Vitamin B 12 | 2003 |
Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.
Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Female; Folic Acid; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Postoperative Complications; Prosthesis Implantation; Stents; Thrombosis; Treatment Outcome; Vitamin B 12 | 2003 |
Homocysteine and lipid levels in young patients with coronary artery disease.
Topics: Adult; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperlipidemias; India; Lipids; Male; Risk Factors | 2003 |
Neurological implications of hyperhomocysteinemia in patients with atherothrombotic disease.
Topics: Brain Ischemia; Coronary Artery Disease; Coronary Thrombosis; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Risk Factors; Stroke | 2003 |
Biochemical markers of vasospastic coronary artery disease.
Topics: Analysis of Variance; Biomarkers; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Vasospasm; Female; Homocysteine; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides | 2003 |
Hyperhomocysteinaemia & folic acid supplementation in patients with high risk of coronary artery disease.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Coronary Artery Disease; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Immunoassay; Male; Microscopy, Fluorescence; Middle Aged; Risk Factors; Time Factors; Vitamin B 12 | 2004 |
Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determination.
Topics: Autoanalysis; Coronary Artery Disease; Female; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Immunoassay; Luminescent Measurements; Male; Reproducibility of Results | 2004 |
Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.
Topics: Aged; Biomarkers; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; DNA Primers; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Severity of Illness Index; Vitamin B 12 | 2004 |
Homocysteine and progression of coronary artery disease.
Topics: Adult; Blood Glucose; Coronary Artery Disease; Disease Progression; Folic Acid; Homocysteine; Humans; Hypertension; Lipids; Male; Middle Aged; Myocardial Infarction; Obesity; Research Design; Risk Factors; Smoking; Vitamin B 12 | 2004 |
[Influence of serum homocysteine level on coronary atherosclerosis in Japanese].
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus; Female; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Multivariate Analysis; Radiography; Risk Factors; Severity of Illness Index; Smoking | 2004 |
Role of plasma homocysteine and lipoprotein (a) in coronary artery disease.
Topics: Adult; Age of Onset; Biomarkers; Coronary Artery Disease; Female; Homocysteine; Humans; Lipoprotein(a); Male; Risk Factors | 2004 |
High dietary methionine plus cholesterol exacerbates atherosclerosis formation in the left main coronary artery of rabbits.
Topics: Animal Feed; Animals; Arterioles; Cholesterol, Dietary; Coronary Artery Disease; Coronary Vessels; Homocysteine; Hyperhomocysteinemia; Male; Methionine; Rabbits; Risk Factors; Tunica Intima; Tunica Media | 2004 |
Hyperhomocysteinemia is associated with human coronary atherosclerosis through the reduction of the ratio of endothelium-bound to basal extracellular superoxide dismutase.
Topics: Biomarkers; Coronary Artery Disease; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Regression Analysis; Risk Factors; Superoxide Dismutase | 2004 |
Ratios of homocysteine and nitrite to high-density lipoprotein in coronary artery patients with the different degree of stenosis.
Topics: Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Constriction, Pathologic; Coronary Artery Disease; Evaluation Studies as Topic; Homocysteine; Humans; Hypercholesterolemia; Hyperlipidemias; Middle Aged; Nitrites; Statistics as Topic; Turkey | 2004 |
Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C-->T mutation on homocysteine concentrations in healthy adults: the ATTICA Study.
Topics: Age Factors; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Diet, Mediterranean; Female; Genotype; Greece; Health Surveys; Homocysteine; Humans; Hypertension; Life Style; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Nutrition Surveys; Obesity; Polymorphism, Genetic; Risk Factors; Sex Factors; Surveys and Questionnaires | 2004 |
Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
Topics: Aged; Biomarkers; C-Reactive Protein; Cell Adhesion Molecules; Coronary Artery Disease; Female; Follow-Up Studies; Homocysteine; Humans; Lipids; Male; Middle Aged; Prognosis; Risk Assessment; Sensitivity and Specificity; von Willebrand Factor | 2004 |
Changes of homocysteine levels and arterial endothelial function in patients with high risk of coronary artery disease after 6-month folic acid supplementation.
Topics: Aged; Arteries; Chromatography, High Pressure Liquid; Coronary Artery Disease; Dietary Supplements; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Time; Treatment Outcome; Vitamin B 12 | 2004 |
Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Chemokine CCL2; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Superoxide Dismutase | 2004 |
[Homocystein and cardiovascular risk: is dosage useful?].
Topics: Adult; Coronary Artery Disease; DNA Mutational Analysis; Genetic Carrier Screening; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Protein S Deficiency; Prothrombin; Recurrence; Risk Factors; Thrombophilia | 2004 |
Plasma homocysteine: an independent or an interactive risk factor for coronary artery disease.
Topics: Age Factors; Chromatography, High Pressure Liquid; Coronary Artery Disease; Female; Homocysteine; Humans; Hypertension; Male; Risk Factors; Sex Factors | 2005 |
Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Topics: Adult; Age Factors; Aged; Alleles; Angiography; Arteriosclerosis; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Cholesterol; Coronary Artery Disease; Female; Gene Frequency; Genotype; Homocysteine; Humans; Lactones; Lipid Metabolism; Male; Middle Aged; Models, Chemical; Myocardial Infarction; Polymorphism, Genetic; Regression Analysis; Time Factors | 2004 |
Antibodies to N-homocysteinylated albumin as a marker for early-onset coronary artery disease in men.
Topics: Adult; Autoantibodies; Autoimmunity; Biomarkers; Case-Control Studies; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Homocysteine; Humans; Immunoglobulin G; Male; Middle Aged; Predictive Value of Tests; Regression Analysis; Serum Albumin | 2005 |
The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
Topics: Adult; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Risk Factors | 2004 |
Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia.
Topics: Adult; Aged; Coronary Artery Disease; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperlipoproteinemia Type II; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymorphism, Genetic; Regression Analysis; Risk Factors; Sex Factors | 2005 |
Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients.
Topics: Aged; Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 1; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Multivariate Analysis; Racial Groups; Severity of Illness Index; Stroke Volume; Systole; Ventricular Dysfunction, Left | 2005 |
Relationship between endothelial dysfunction and serum homocysteine in patients with coronary lesions.
Topics: Aged; Biomarkers; Cell Count; Coronary Artery Disease; Endothelial Cells; Endothelin-1; Female; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide | 2005 |
Impact of elevated plasma total homocysteine concentration on coronary atherosclerosis in Chinese patients with acute myocardial infarction undergoing primary coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Female; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors; Sex Factors | 2005 |
Hyperhomocysteinemia: an additional risk factor in white coat hypertension.
Topics: Blood Pressure Monitoring, Ambulatory; Body Mass Index; Coronary Artery Disease; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Male; Middle Aged; Office Visits; Retinal Diseases; Risk Factors; Smoking | 2005 |
Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: associated factors.
Topics: Aged; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Exercise Test; Female; Homocysteine; Humans; Intracranial Arteriosclerosis; Lipoprotein(a); Male; Middle Aged; Myocardial Ischemia; Myocardium; Odds Ratio; Perfusion; Radionuclide Imaging; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2005 |
Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blotting, Western; Cells, Cultured; Coronary Artery Disease; Coronary Vessels; Down-Regulation; Endothelium, Vascular; Ginsenosides; Homocysteine; Immunohistochemistry; In Vitro Techniques; Luminescent Measurements; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymerase Chain Reaction; RNA, Messenger; Superoxides; Swine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2005 |
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |
Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease.
Topics: Coronary Artery Disease; Diet Therapy; Female; Genetic Testing; Homocysteine; Homocystinuria; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis | 2005 |
Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Coronary Artery Disease; Female; Folic Acid; Genotype; Homocysteine; Humans; Korea; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Nutritional Status; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Vitamin B 12 | 2006 |
Plasma homocysteine predicts progression of atherosclerosis.
Topics: Adult; Aged; C-Reactive Protein; Calcinosis; Cohort Studies; Coronary Artery Disease; Coronary Disease; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Tomography, X-Ray Computed | 2005 |
Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
Topics: Angina Pectoris; Autoantibodies; Biomarkers; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Lipoproteins, LDL; Male; Middle Aged | 2005 |
Plasma homocysteine levels in patients with isolated coronary artery ectasia.
Topics: Biomarkers; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Dilatation, Pathologic; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prospective Studies; Vitamin B 12 | 2005 |
Homocysteine is positively associated with cytokine IL-18 plasma levels in coronary artery bypass surgery patients.
Topics: Aged; Aged, 80 and over; Coronary Artery Bypass; Coronary Artery Disease; Female; Homocysteine; Humans; Interleukin-18; Male; Middle Aged | 2005 |
[Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment].
Topics: Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Genetic Predisposition to Disease; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Assessment | 2005 |
[Hyperhomocysteinemia as a risk factor for coronary atherosclerotic diseases in the elderly].
Topics: Aged; Aged, 80 and over; Brazil; Coronary Angiography; Coronary Artery Disease; Epidemiologic Methods; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Smoking | 2005 |
[Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke].
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Fibrinogen; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Life Style; Lipoprotein(a); Male; Risk Factors; Stroke; Time Factors; Triglycerides; von Willebrand Factor | 2005 |
The influence of genetic and environmental factors on plasma homocysteine concentrations in a population at high risk for coronary artery disease.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Coronary Artery Disease; Cystathionine beta-Synthase; Environment; Erythrocytes; Female; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Polymorphism, Genetic; Risk Factors; Vitamin B 12; Vitamin B 6 | 2005 |
Association of MTRRA66G polymorphism (but not of MTHFR C677T and A1298C, MTRA2756G, TCN C776G) with homocysteine and coronary artery disease in the French population.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Alleles; Case-Control Studies; Coronary Artery Disease; Female; Ferredoxin-NADP Reductase; Folic Acid; France; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Transcobalamins; Vitamin B 12; White People | 2005 |
Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease?
Topics: Adult; C-Reactive Protein; Cholesterol; Coronary Artery Disease; Echocardiography; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Homocysteine; Humans; Insulin; Polycystic Ovary Syndrome; Triglycerides | 2006 |
Determination of risk factors in obese and non-obese patients with coronary artery disease.
Topics: Age Distribution; Body Mass Index; C-Reactive Protein; Case-Control Studies; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Female; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Incidence; Logistic Models; Male; Middle Aged; Multivariate Analysis; Obesity; Odds Ratio; Predictive Value of Tests; Probability; Risk Factors; Severity of Illness Index; Sex Distribution; Smoking | 2005 |
Homocysteine: call off the funeral.
Topics: Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Stroke; Vitamin B 12 | 2006 |
Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin.
Topics: Aged; Aged, 80 and over; Aminocaproic Acid; Angiostatins; Apolipoproteins A; Aspirin; Atherosclerosis; Cell Movement; Cells, Cultured; Chemotaxis, Leukocyte; Coronary Artery Disease; Coronary Vessels; Endothelial Cells; Endothelium, Vascular; Female; Gene Expression Regulation; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipoprotein(a); Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Male; Middle Aged; Monocytes; NF-kappa B; Plasminogen; Protein Binding; Protein Structure, Tertiary; Transfection | 2006 |
Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk.
Topics: Aged; Calcinosis; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Risk Factors; Tomography, X-Ray Computed | 2006 |
Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Analysis of Variance; Case-Control Studies; Coronary Artery Disease; Female; Ferredoxin-NADP Reductase; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Middle Aged; Mutation; Polymorphism, Genetic; Risk Factors; Statistics, Nonparametric | 2006 |
Homocysteine and nitric oxide in patients undergoing diagnostic coronary angiography.
Topics: Adult; Aged; Coronary Angiography; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide; Risk Factors | 2006 |
Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
Topics: Acute Disease; Adult; Aged; Blood Coagulation; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus; Drug Resistance; Fibrin; Fibrinolytic Agents; Folic Acid; Hematinics; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Male; Middle Aged; Permeability; Recombinant Proteins; Tissue Plasminogen Activator | 2006 |
[An association with the values of homocystein with the course of a postinfarct period in patients of different age].
Topics: Adult; Aged; Angina Pectoris; Biomarkers; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction | 2006 |
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women.
Topics: Aged; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Longitudinal Studies; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Postmenopause; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Survival Rate; Time Factors; White People | 2006 |
Hyperhomocystinemia in patients with coronary artery disease.
Topics: Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Severity of Illness Index | 2006 |
C-reactive protein in predicting coronary artery disease in subjects with aortic valve sclerosis before diagnostic coronary angiography.
Topics: Age Factors; Aged; Aortic Valve; C-Reactive Protein; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Echocardiography; Female; Heart Valve Diseases; Homocysteine; Humans; Hypertension; Male; Middle Aged; Regression Analysis; Sclerosis | 2006 |
Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
Topics: Arabs; Case-Control Studies; Cholesterol; Coronary Artery Disease; Creatinine; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Triglycerides; Tunisia | 2006 |
Carotid intima-media thickness in coronary slow flow: relationship with plasma homocysteine levels.
Topics: Aged; Carotid Arteries; Carotid Artery Diseases; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Reference Values; Tunica Intima; Tunica Media | 2006 |
[Homocysteine level, relationship with cardiovascular risk factors in selected Polish population].
Topics: Adult; Aged; Coronary Artery Disease; Environmental Monitoring; Epidemiological Monitoring; Female; Folic Acid; Health Status; Homocysteine; Humans; Life Style; Male; Middle Aged; Poland; Risk Factors; Rural Population; Smoking; Urban Population; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2005 |
Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Topics: Adrenergic beta-Antagonists; Adult; Calcinosis; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Glomerular Filtration Rate; Homocysteine; Humans; Lupus Erythematosus, Systemic; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Regression Analysis; Severity of Illness Index; Tomography, X-Ray Computed | 2006 |
A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.
Topics: Aged; Cohort Studies; Comorbidity; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Germany; Homocysteine; Humans; Linear Models; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate | 2006 |
Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002.
Topics: Age of Onset; Ankle; Blood Pressure; Brachial Artery; Coronary Artery Disease; Demography; Female; Fibrinogen; Health Surveys; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Nutrition Surveys; Peripheral Vascular Diseases; Prevalence; Risk Factors; United States | 2006 |
Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.
Topics: Aged; Animals; Apolipoprotein A-I; Apolipoproteins E; Biological Transport; Cells, Cultured; Cholesterol; Cholesterol, HDL; Coronary Artery Disease; Cystathionine; Hepatocytes; Homocysteine; Humans; Hyperhomocysteinemia; Lipoproteins, HDL; Male; Mice; Mice, Knockout; Middle Aged | 2006 |
Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery disease.
Topics: Aged; Coronary Artery Disease; Female; Heart Failure; Homocysteine; Humans; Male; Middle Aged; Stroke Volume; Ventricular Dysfunction, Left | 2007 |
Homocysteine, traditional risk factors and impaired renal function in coronary artery disease.
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Polymorphism, Genetic; Risk Factors; Vitamin B Complex | 2006 |
Increased plasma homocysteine and allantoin levels in coronary artery disease: possible link between homocysteine and uric acid oxidation.
Topics: Adult; Aged; Allantoin; Coronary Artery Disease; Female; Homocysteine; Homocystine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Oxidation-Reduction; Reactive Oxygen Species; Uric Acid | 2006 |
Homocysteine, vitamin B12 and folate levels in premature coronary artery disease.
Topics: Adult; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Prevalence; Risk Factors; Sex Characteristics; Vitamin B 12; Vitamin B 12 Deficiency | 2006 |
Ginkgolide A attenuates homocysteine-induced endothelial dysfunction in porcine coronary arteries.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Down-Regulation; Endothelium, Vascular; Ginkgo biloba; Homocysteine; In Vitro Techniques; Nitric Oxide Synthase Type III; Phytotherapy; Plant Preparations; Polymerase Chain Reaction; Risk Factors; RNA; Swine; Treatment Outcome; Vasodilation | 2006 |
Circulating homocysteine levels in patients with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Folic Acid; Genotype; Glomerular Filtration Rate; Glycated Hemoglobin; Homocysteine; Humans; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymorphism, Genetic; Up-Regulation; Vitamin B 12 | 2008 |
[Homocysteinemia and coronary artery disease: a case-control study in a Tunisian population].
Topics: Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Tunisia | 2006 |
Abnormal asymmetric dimethylarginine/nitric oxide balance in patients with documented coronary artery disease: relation to renal function and homocysteine.
Topics: Aged; Arginine; Case-Control Studies; Coronary Artery Disease; Female; Homeostasis; Homocysteine; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Nitric Oxide | 2007 |
Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance.
Topics: Adult; Aged; Arginine; Blood Glucose; C-Reactive Protein; Cholesterol; Coronary Artery Disease; Discriminant Analysis; Female; Glucose Clamp Technique; Homocysteine; Humans; Insulin Resistance; Male; Middle Aged; Risk Factors; Triglycerides | 2007 |
Hyperhomocysteinemia and mortality after coronary artery bypass grafting.
Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors | 2006 |
[Evaluation of MTHFR C677T gene polymorphism and homocysteine level in coronary atherosclerotic disease].
Topics: Adult; Brazil; Case-Control Studies; Coronary Artery Disease; Female; Gene Frequency; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Factors | 2006 |
Relationship of the 1793G-A and 677C-T polymorphisms of the 5,10-methylenetetrahydrofolate reductase gene to coronary artery disease.
Topics: Coronary Artery Disease; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Point Mutation; Polymorphism, Genetic | 2006 |
Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow.
Topics: Adult; Aged; Blood Flow Velocity; Coronary Artery Disease; Coronary Circulation; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Oxidative Stress | 2007 |
Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects.
Topics: Adult; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Coronary Thrombosis; Female; Homocysteine; Humans; Intracranial Arteriosclerosis; Intracranial Thrombosis; Male; Middle Aged; Prospective Studies; Risk Factors; Stroke; Vitamin B 6 | 2007 |
Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis.
Topics: Age Factors; Aged; C-Reactive Protein; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Creatinine; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Male; Metabolic Clearance Rate; Middle Aged; Prevalence; Renal Artery Obstruction; Risk Factors | 2007 |
Plasma homocysteine levels and late outcome in patients with unstable angina.
Topics: Aged; Angina, Unstable; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prognosis; Recurrence; Risk Factors; Time Factors | 2007 |
[In patients with coronary artery disease and left ventricular contractile insufficiency the pathogenicity of smoking associates with imbalance in metabolism of homocysteine].
Topics: Adult; Comorbidity; Coronary Angiography; Coronary Artery Disease; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Smoking; Stroke Volume; Ventricular Dysfunction, Left | 2006 |
Autoantibodies against N-homocysteinylated proteins in patients on long-term haemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Coronary Artery Disease; Female; Hemoglobins; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Serum Albumin; Time Factors | 2007 |
[Asymmetric dimethyl arginine (ADMA): a novel cardiovascular risk factor?].
Topics: Arginine; Coronary Artery Disease; Diabetes Mellitus, Type 2; Endothelium, Vascular; Homocysteine; Humans; Insulin Resistance; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase; Statistics as Topic | 2007 |
Effects of heparin on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells.
Topics: Animals; Anticoagulants; Aorta; Cells, Cultured; Coronary Artery Disease; Enzyme Induction; Heparin; Homocysteine; In Vitro Techniques; Matrix Metalloproteinase 2; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley | 2007 |
Homocysteine and methylenetetrahydrofolate reductase in subjects undergoing coronary angiography.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Point Mutation; Polymorphism, Genetic; Risk Factors; Severity of Illness Index | 2007 |
Whole grain intake and its cross-sectional association with obesity, insulin resistance, inflammation, diabetes and subclinical CVD: The MESA Study.
Topics: Aged; Aged, 80 and over; Albuminuria; Body Mass Index; C-Reactive Protein; Calcinosis; Cardiovascular Diseases; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus; Diet; Edible Grain; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Prospective Studies | 2007 |
Hostility and serum homocysteine as cardiovascular risk factors in Korean patients with coronary artery disease.
Topics: Adult; Coronary Artery Disease; Cross-Sectional Studies; Female; Homocysteine; Hostility; Humans; Korea; Male; Middle Aged; Risk Factors | 2007 |
Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions.
Topics: Aged; Angiography; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Stroke Volume; Systole; Ventricular Dysfunction, Left | 2007 |
Associations between markers of subclinical atherosclerosis and dietary patterns derived by principal components analysis and reduced rank regression in the Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; C-Reactive Protein; Calcinosis; Carotid Artery, Common; Carotid Artery, Internal; Coronary Artery Disease; Diet; Feeding Behavior; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Principal Component Analysis; Regression Analysis; Tunica Intima | 2007 |
Influence of 677 C-->T polymorphism of methylenetetrahydrofolate reductase on medium-term prognosis after acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Genetic Predisposition to Disease; Homocysteine; Humans; Kaplan-Meier Estimate; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Syndrome; Time Factors | 2007 |
Homocysteinemia as an independent risk factor in the Chinese population at a high risk of coronary artery disease.
Topics: China; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors | 2007 |
Whole body nitric oxide production is not decreased in patients with coronary atherosclerosis but is inversely related to plasma homocysteine.
Topics: Arginine; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrogen Isotopes | 2008 |
[Hyperhomocysteinemia in coronary artery disease and hemostasis disorders in patients with type 2 diabetes mellitus].
Topics: Blood Coagulation; Blood Platelets; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Tomography, Spiral Computed | 2007 |
Homocysteine (Hcy) follow-up study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prospective Studies; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Vitamin B 12; Vitamin B Complex | 2007 |
Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Female; Fibrin; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged | 2007 |
Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease.
Topics: Age Factors; Aged; Arginine; Biomarkers; Cohort Studies; Coronary Artery Disease; Cystatin C; Cystatins; Female; Glomerular Filtration Rate; Homocysteine; Humans; Male; Middle Aged; Renal Insufficiency; Risk Factors | 2008 |
Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoantibodies; Case-Control Studies; Coronary Artery Disease; Endothelin-1; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Lipoprotein Lipase; Lipoproteins, LDL; Middle Aged; Risk Factors; Thrombosis | 2007 |
Correlation of hyperhomocysteinaemia and Chlamydia pneumoniae IgG seropositivity with coronary artery disease in a general population.
Topics: Adult; Aged; Antibodies, Bacterial; C-Reactive Protein; Case-Control Studies; Chlamydophila Infections; Chlamydophila pneumoniae; Cohort Studies; Coronary Artery Disease; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Hyperhomocysteinemia; Immunoglobulin G; Information Systems; Male; Middle Aged | 2007 |
Modulation of erythrocyte sensitivity to oxidative stress by transient hyperhomocysteinemia in healthy subjects and in patients with coronary artery disease.
Topics: Adult; Aged; alpha-Tocopherol; Analysis of Variance; Area Under Curve; Coronary Artery Disease; Erythrocytes; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lipid Peroxidation; Male; Methionine; Middle Aged; Oxidation-Reduction; Oxidative Stress | 2008 |
[The some risk factors for atherosclerosis in men with coronary artery disease depending on the age].
Topics: Age Factors; Aged; Case-Control Studies; Causality; Comorbidity; Coronary Artery Disease; Homocysteine; Humans; Male; Middle Aged; Protein C; Radiography; Risk Factors; Tumor Necrosis Factor-alpha | 2007 |
The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels.
Topics: Aged; Coronary Artery Disease; Female; Folic Acid; Gene Frequency; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors; Turkey; Vitamin B 12 | 2008 |
Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease.
Topics: Coronary Artery Disease; Enzyme Stability; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Phenotype; Polymorphism, Single Nucleotide; Regression Analysis | 2008 |
Waist-to-hip ratio correlates with homocysteine levels in male patients with coronary artery disease.
Topics: Aged; Biomarkers; Body Mass Index; Coronary Artery Disease; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Obesity; Risk Factors; Vitamin B 12; Waist-Hip Ratio | 2008 |
Homocysteine and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Tunisian patients with severe coronary artery disease.
Topics: Aged; Case-Control Studies; Coronary Artery Disease; Female; Gene Frequency; Haplotypes; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Polymorphism, Single Nucleotide; Tunisia | 2009 |
Direct effect of statins on homocysteine-induced endothelial adhesiveness: potential impact to human atherosclerosis.
Topics: Aged; Anticholesteremic Agents; Case-Control Studies; Cell Adhesion; Cell Adhesion Molecules; Coronary Artery Disease; Endothelial Cells; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Pravastatin; Simvastatin | 2008 |
Homocysteine and C-reactive protein are not markers of cognitive impairment in patients with major cardiovascular disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Cognition Disorders; Coronary Artery Bypass; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Prevalence; Risk Factors | 2008 |
Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Cholesterol; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Odds Ratio; Pyridoxal Phosphate; Risk Factors; Vitamin B 6; Vitamin B 6 Deficiency; Vitamin B Complex | 2008 |
Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
Topics: Adult; Aged; Alleles; Case-Control Studies; Coronary Artery Disease; Female; Gene Frequency; Genotype; Haplotypes; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Portugal; Risk Factors | 2008 |
Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
Topics: C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Lipoprotein(a); Male; Metabolic Syndrome; Middle Aged; Prevalence; Risk Factors; Turkey; Uric Acid | 2008 |
Elevated levels of homocysteine predict cardiovascular death, nonfatal myocardial infarction, and symptomatic bypass graft disease at 2-year follow-up following coronary artery bypass surgery.
Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Female; Follow-Up Studies; Graft Occlusion, Vascular; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Treatment Outcome | 2008 |
C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease.
Topics: C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Genetic | 2009 |
Plasma homocysteine levels & 677C-->T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity.
Topics: Aged; Atherosclerosis; Coronary Artery Disease; Demography; Genetic Predisposition to Disease; Genotype; Heterozygote; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic | 2008 |
Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
Topics: Adolescent; Adult; Age Factors; Body Mass Index; Calcinosis; Clinical Trials as Topic; Cohort Studies; Coronary Artery Disease; Diabetes Complications; Female; Homocysteine; Humans; Lipoprotein(a); Lupus Erythematosus, Systemic; Male; Middle Aged; Prospective Studies; Risk Factors; Tomography, Spiral Computed | 2008 |
Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease.
Topics: Age Factors; Aged; Case-Control Studies; Coronary Artery Disease; Female; Folic Acid Deficiency; Homocysteine; Humans; Male; Middle Aged; Odds Ratio; Pyridoxal Phosphate; Risk Factors; Sex Factors; Vitamin B 12 Deficiency; Vitamin B 6 Deficiency | 1995 |
Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease.
Topics: Coronary Angiography; Coronary Artery Disease; Discriminant Analysis; Female; Homocysteine; Homocystinuria; Hot Temperature; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Risk Factors | 1993 |
Evaluation of the presence of premature atherosclerosis in adults with heterozygosity for cystathionine-beta-synthase deficiency.
Topics: Adolescent; Adult; Arteriosclerosis; Blood Circulation; Carotid Stenosis; Cerebral Arterial Diseases; Coronary Artery Disease; Cystathionine beta-Synthase; Female; Femoral Artery; Heterozygote; Homocysteine; Homocystinuria; Humans; Male; Methionine; Middle Aged; Peripheral Vascular Diseases; Tunica Intima; Tunica Media | 1996 |
Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.
Topics: Adult; Case-Control Studies; China; Cholesterol; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Hong Kong; Humans; Male; Middle Aged; Prevalence; Risk Factors; Smoking; Vitamin B 12 | 1996 |
Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis.
Topics: Adult; Aging; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Erythrocytes; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Pyridoxal Phosphate; Risk Factors; Sex Characteristics; Vitamin B 12; Vitamin B Complex | 1997 |
The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
Topics: Adult; Aged; Alcohol Drinking; Case-Control Studies; Comorbidity; Coronary Artery Disease; Disease Susceptibility; Erythrocytes; Fasting; Female; Folic Acid; Genes; Genotype; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; Smoking | 1997 |
Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease.
Topics: Biomarkers; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Female; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Risk Factors; Smoking | 1997 |
Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone.
Topics: Arteries; Cell Extracts; Coronary Artery Disease; Coronary Vessels; Culture Techniques; Cysteine; Cystine; Disulfides; Dithionitrobenzoic Acid; Endothelium, Vascular; Extracellular Matrix; Homocysteine; Homocystine; Humans; Isometric Contraction; Metalloendopeptidases; Oxidation-Reduction; Vasoconstriction | 1998 |
Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis.
Topics: Adult; Aged; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Pyridoxine; Regression Analysis; Risk Factors; Vitamin B 12 | 1998 |
Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.
Topics: Aged; Analysis of Variance; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Mortality; Multivariate Analysis; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Single-Blind Method | 1999 |
Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Japan; Male; Middle Aged; Risk Factors | 1999 |
Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Topics: Aged; Arteriosclerosis; Coronary Artery Disease; Cross-Sectional Studies; Erythrocytes; Female; Folic Acid; Homocysteine; Homocystine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Renal Dialysis; Retrospective Studies; Risk Factors; Sex Factors; Vitamin B 12 | 1999 |
Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries.
Topics: Acute-Phase Reaction; Adult; Aged; Arteritis; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Constriction, Pathologic; Coronary Artery Disease; Female; Fibrinogen; Homocysteine; Humans; Interleukin-6; Intermittent Claudication; Logistic Models; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Popliteal Artery; Risk Assessment; Transforming Growth Factor beta; Triglycerides | 1999 |
Effects of chelation with EDTA and vitamin B therapy on nitric oxide-related endothelial vasodilator function.
Topics: Acetylcholine; Analysis of Variance; Chelating Agents; Coronary Artery Disease; Drug Therapy, Combination; Edetic Acid; Female; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide; Nitroprusside; Regional Blood Flow; Vasodilation; Vitamin B Complex | 1999 |
Plasma homocysteine level and development of coronary artery disease.
Topics: Adult; Age of Onset; Aged; Coronary Artery Disease; Coronary Disease; Homocysteine; Humans; Lipids; Male; Middle Aged; Prospective Studies; Risk Factors; Severity of Illness Index | 1999 |
Serum glutathione in adolescent males predicts parental coronary heart disease.
Topics: Adolescent; Aged; Anthropometry; Blood Pressure; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Coronary Disease; Glutathione; Homocysteine; Humans; Lipids; Logistic Models; Male; Middle Aged; Ohio; Oxidation-Reduction; Oxidative Stress; Parents; Sulfhydryl Compounds | 1999 |
[Plasma homocysteine is not a predictive factor of restenosis after coronary angioplasty].
Topics: Aged; Angioplasty, Balloon; Biomarkers; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence | 1999 |
Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study.
Topics: Adult; Age Distribution; Aged; Biomarkers; Chronic Disease; Confidence Intervals; Coronary Artery Disease; Female; Follow-Up Studies; Graft Survival; Homocysteine; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Sex Distribution; Survival Rate | 2000 |
Tumour necrosis factor alpha G-308-->A polymorphism and risk for coronary artery disease.
Topics: Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Obesity; Polymorphism, Genetic; Risk Factors; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2000 |
Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Middle Aged; Odds Ratio; Postmenopause; Reference Values; Risk Factors; ROC Curve | 2000 |
Total plasma homocysteine concentrations in Puerto Rican patients with presumptive atherosclerotic coronary disease.
Topics: Angiography; Catchment Area, Health; Chromatography, High Pressure Liquid; Coronary Artery Disease; Female; Homocysteine; Humans; Incidence; Male; Middle Aged; Predictive Value of Tests; Puerto Rico; Severity of Illness Index | 2000 |
Correlation of homocytsteine levels with the extent of coronary atherosclerosis in patients with low cardiovascular risk profiles.
Topics: Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Female; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Hypertension; Linear Models; Male; Middle Aged; Risk Factors; Severity of Illness Index; Smoking | 2000 |
Plasma homocysteine and severity of thoracic aortic atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Biomarkers; Cholesterol; Coronary Artery Disease; Cross-Sectional Studies; Echocardiography, Transesophageal; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Vitamin B 12 | 2000 |
Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk.
Topics: Coronary Artery Disease; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors | 2001 |
C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis.
Topics: Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Calcinosis; Case-Control Studies; Cholesterol, LDL; Confidence Intervals; Coronary Artery Disease; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Middle Aged; Military Personnel; Prognosis; Prospective Studies; Risk Factors; Severity of Illness Index; Tomography, X-Ray Computed | 2001 |
Prevalence of new coronary risk factors in Thai population.
Topics: Adult; Chlamydia Infections; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Risk Factors; Thailand | 2000 |
[Homocysteine--CRP--lipoprotein (a). When do you evaluate the "new" risk factors].
Topics: Arteriosclerosis; C-Reactive Protein; Coronary Artery Disease; Homocysteine; Humans; Lipoprotein(a); Risk Factors | 2001 |
Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
Topics: Adult; Aged; Coronary Artery Disease; Coronary Disease; Creatinine; Edible Grain; Female; Flour; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Renal Insufficiency; Risk Factors; Vitamin B 12 | 2001 |
The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis.
Topics: Adult; Case-Control Studies; Coronary Artery Disease; Cysteine; Female; Homocysteine; Humans; Male; Middle Aged; Reference Values; Risk Factors | 2001 |
The effect of polymorphisms of MTHER gene and vitamin B on hyperhomocysteinemia.
Topics: Aged; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Point Mutation; Polymorphism, Restriction Fragment Length; Vitamin B 12 | 2001 |
Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice.
Topics: Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Collagen; Coronary Artery Disease; Dietary Supplements; Female; Homocysteine; Hyperhomocysteinemia; Lipids; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Thrombosis | 2001 |
Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease.
Topics: Adult; Age of Onset; Analysis of Variance; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction | 2001 |
Extent of coronary atherosclerosis and homocysteine affect endothelial markers.
Topics: Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Disease; E-Selectin; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Vascular Cell Adhesion Molecule-1 | 2001 |
Levels of plasma homocysteine in persons with spinal cord injury.
Topics: Adult; Age Factors; Aged; California; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Rehabilitation Centers; Risk Assessment; Sex Factors; Spinal Cord Injuries | 2001 |
Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Arterial Occlusive Diseases; Case-Control Studies; Cerebrovascular Disorders; China; Coronary Artery Disease; Cystathionine beta-Synthase; Enzymes; Female; Gene Frequency; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Myocardial Infarction; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic | 2001 |
Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C-->T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients.
Topics: Adult; Aged; Coronary Artery Disease; Female; Folic Acid; Genotype; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Function Tests; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Postoperative Complications; Prognosis; Risk Factors | 2001 |
Folate reduces homocysteine levels and lowers rate of restenosis.
Topics: Coronary Artery Disease; Folic Acid; Homocysteine; Humans; Secondary Prevention; Stents | 2001 |
Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease.
Topics: Coronary Artery Disease; Cost-Benefit Analysis; Dietary Supplements; Folic Acid; Homocysteine; Humans; Vitamins | 2002 |
Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease.
Topics: Coronary Artery Disease; Cost-Benefit Analysis; Dietary Supplements; Folic Acid; Homocysteine; Humans; Vitamins | 2002 |
Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease.
Topics: Coronary Artery Disease; Cost-Benefit Analysis; Dietary Supplements; Folic Acid; Homocysteine; Humans; Vitamins | 2002 |
Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease.
Topics: Adult; Antibodies, Bacterial; Austria; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Multicenter Studies as Topic; Risk Factors; Seroepidemiologic Studies; Smoking | 2002 |
Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Female; Folic Acid; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Malabsorption Syndromes; Male; Middle Aged; Risk Factors; Vitamin B 12 | 2002 |
Elevated homocysteine levels might be associated with coronary artery remodeling in patients with stable angina: an intravascular ultrasound study.
Topics: Analysis of Variance; Angina Pectoris; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Vessels; Female; Homocysteine; Humans; Linear Models; Lipids; Male; Middle Aged; Ultrasonography, Interventional | 2002 |
Hyperhomocysteinemia and the risk of thromboembolic phenomenon in patients with chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Coronary Artery Disease; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies; Risk Factors; Thromboembolism | 2002 |
A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism.
Topics: Aged; Coronary Artery Disease; Female; Folic Acid; Gene Frequency; Homocysteine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors | 2002 |
Elevated fibrinogen and homocysteine levels enhance the risk of mortality in patients from a high-risk preventive cardiology clinic.
Topics: Aged; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Heart Diseases; Homocysteine; Humans; Longitudinal Studies; Male; Middle Aged; Prevalence; Regression Analysis; Risk Factors; Thrombosis | 2002 |
Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis.
Topics: Adult; Anticoagulants; Choline; Coronary Artery Disease; Coronary Disease; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hydroxyethylrutoside; Lipids; Male; Middle Aged; Pyridoxine; Riboflavin; Vitamin B 12 | 1989 |